
  
    
      
        Background_NNP
        The_DT presence_NN and_CC abundance_NN of_IN long_JJ chain_NN polyunsaturated_JJ
        fatty_NN acids_NNS (_( LC-PUFA_NNP )_) in_IN humans_NNS diets_NNS have_VBP been_VBN the_DT basis_NN
        of_IN scientific_JJ investigations_NNS for_IN decades_NNS ._. Studies_NNS have_VBP yet_RB
        to_TO resolve_VB all_DT the_DT mechanisms_NNS of_IN action_NN of_IN LC-PUFA_NNP ,_, in_IN
        particular_JJ the_DT remarkable_JJ phenotypic_JJ differences_NNS between_IN
        populations_NNS that_WDT consume_VBP different_JJ quantities_NNS of_IN fish_NN and_CC
        fish_NN oil_NN in_IN their_PRP$ diets_NNS [_NN 1_CD 2_CD 3_CD 4_CD 5_CD ]_NN ._. Dietary_NNP LC-PUFA_NNP
        affect_VB processes_VBZ including_VBG :_: growth_NN ,_, neurological_JJ
        development_NN ,_, lean_JJ and_CC fat_JJ mass_NN accretion_NN ,_, reproduction_NN ,_,
        innate_JJ and_CC acquired_VBN immunity_NN ,_, infectious_JJ pathologies_NNS of_IN
        viruses_NNS ,_, bacteria_NNS and_CC parasites_NNS ;_: and_CC the_DT incidence_NN and_CC
        severity_NN of_IN virtually_RB all_DT chronic_JJ and_CC degenerative_JJ diseases_NNS
        including_VBG cancer_NN ,_, atherosclerosis_NNS ,_, stroke_NN ,_, arthritis_NN ,_,
        diabetes_NN ,_, osteoporosis_NNS ,_, and_CC neurodegenerative_JJ ,_,
        inflammatory_JJ ,_, and_CC skin_NN diseases_NNS [_NN 6_CD 7_CD 8_CD 9_CD 10_CD 11_CD ]_NN ._. Due_JJ to_TO
        lack_NN of_IN mechanistic_JJ knowledge_NN ,_, predictions_NNS for_IN optimal_NN
        intake_NN of_IN nutritionally_RB important_JJ LC-PUFA_NNP remain_VB vague_JJ and_CC
        dietary_JJ recommendations_NNS simply_RB relate_VBP to_TO prevention_NN of_IN
        overt_JJ deficiency_NN ._. There_EX is_VBZ not_RB even_RB scientific_JJ consensus_NN on_IN
        whether_IN LC-PUFA_NNP present_JJ in_IN human_JJ milk_NN should_MD be_VB included_VBN in_IN
        infant_NN formulas_NNS [_NN 12_CD ]_NN ._.
        The_DT most_RBS often_RB cited_VBD action_NN of_IN n_NN 3_CD LC-PUFA_NNP is_VBZ that_IN they_PRP
        induce_VB alterations_NNS in_IN eicosanoids_NNS by_IN antagonizing_VBG the_DT
        primary_JJ substrate_NN of_IN eicosanoid_NN metabolism_NN :_: arachidonic_JJ
        acid_NN (_( AA_NN )_) [_NN 13_CD ]_NN ._. Certainly_RB ,_, n_NN 3_CD LC-PUFA_NNP replace_VB AA_NN in_IN
        cellular_JJ membranes_NNS to_TO some_DT extent_NN and_CC alter_VB eicosanoid_NN
        products_NNS ,_, but_CC is_VBZ this_DT the_DT primary_JJ mechanism_NN underlying_VBG the_DT
        benefits_NNS of_IN consuming_NN fish_NN ?_. The_DT n_NN 3_CD LC-PUFA_NNP alter_VB
        postprandial_NN lipoprotein_NN production_NN and_CC clearance_NN ,_, and_CC
        lower_JJR circulating_VBG triglyceride-rich_JJ lipoproteins_NNS [_NN 14_CD ]_NN ._.
        N_NNP 3_CD LC-PUFA_NNP induce_VB alterations_NNS in_IN membrane_NN properties_NNS
        including_VBG ion_NN transport_NN ,_, trafficking_NN and_CC vesicular_NN
        transport_NN ,_, and_CC alter_VB the_DT transcription_NN of_IN genes_NNS encoding_VBG
        proteins_NNS in_IN lipid_NN biosynthesis_NNS ,_, lipid_NN desaturation_NN ,_, and_CC
        lipid_NN oxidation_NN [_NN 15_CD 16_CD 17_CD 18_CD 19_CD ]_NN ._.
        Fish_NN oil_NN contains_VBZ ,_, among_IN others_NNS ,_, docosahexaenoic_JJ acid_NN
        (_( DHA_NNP ;_: 22_CD :_: 6_CD n_NN 3_LS )_) and_CC eicosapentaenoic_JJ acid_NN (_( EPA_NNP ;_: 20_CD :_: 5_CD n_NN 3_LS )_) as_IN
        important_JJ components_NNS ._. The_DT concentration_NN of_IN DHA_NNP in_IN the_DT
        retina_NN and_CC neurological_JJ membranes_NNS suggests_VBZ a_DT specific_JJ role_NN
        for_IN DHA_NNP in_IN the_DT brain_NN ._. However_RB ,_, neither_DT the_DT mechanism_NN of_IN
        uptake_NN nor_CC the_DT precise_JJ role_NN of_IN DHA_NNP in_IN the_DT brain_NN is_VBZ
        currently_RB well_RB understood_VBN [_NN 20_CD ]_NN ._. Rigorous_NNP elimination_NN of_IN
        DHA_NNP and_CC its_PRP$ precursor_NN 18_CD :_: 3_CD n_NN 3_CD from_IN animal_NN diets_NNS leads_VBZ to_TO
        limited_JJ ,_, but_CC significant_JJ ,_, phenotypic_JJ effects_NNS [_NN 21_CD ]_NN ._. The_DT
        basic_JJ biochemical_JJ pathway_NN of_IN DHA_NNP biosynthesis_NNS from_IN its_PRP$
        precursor_NN 18_CD :_: 3_CD n_NN 3_CD is_VBZ still_RB being_VBG resolved_VBN [_NN 22_CD ]_NN ._. The_DT EPA_NNP
        component_NN of_IN fish_NN oil_NN is_VBZ linked_VBN to_TO anti-inflammatory_JJ ,_,
        anti-thrombotic_JJ ,_, and_CC generally_RB ,_, eicosanoid-mediated_JJ effects_NNS
        by_IN antagonizing_VBG AA_NN metabolism_NN ._.
        Arachidonic_NNP acid_NN (_( AA_NN ;_: 20_CD :_: 4_CD n_NN 6_CD )_) ,_, either_CC formed_VBD from_IN n_NN 6_CD
        precursors_NNS in_IN mammals_NNS or_CC obtained_VBN directly_RB from_IN the_DT diet_NN ,_,
        is_VBZ believed_VBN to_TO exert_VB most_JJS of_IN its_PRP$ biological_JJ activity_NN via_IN
        conversion_NN to_TO various_JJ eicosanoids_NNS ._. N_NNP 6_CD LC-PUFA_NNP ,_, and_CC
        especially_RB AA_NN ,_, are_VBP also_RB now_RB recognized_VBN to_TO elicit_NN
        significant_JJ physiological_JJ effects_NNS when_WRB consumed_VBN in_IN the_DT
        diet_NN ._. The_DT lack_NN of_IN significant_JJ commercial_JJ sources_NNS of_IN AA_NN has_VBZ
        limited_VBD the_DT study_NN of_IN this_DT fatty_NN acid_NN (_( FA_NNP )_) as_IN a_DT dietary_JJ
        ingredient_NN until_IN relatively_RB recently_RB ._. Due_JJ to_TO the_DT
        commercialization_NN of_IN fungal_NN biomass_NNS production_NN to_TO produce_VB
        very_RB high_JJ levels_NNS of_IN AA_NN as_IN a_DT storage_NN oil_NN ,_, it_PRP is_VBZ now_RB possible_JJ
        to_TO study_VB this_DT FA_NNP ._.
        Until_IN recently_RB ,_, LC-PUFA_NNP effects_NNS on_IN gene_NN transcription_NN
        were_VBD thought_VBN primarily_RB to_TO be_VB mediated_JJ by_IN a_DT single_NN subfamily_RB
        of_IN orphan_JJ nuclear_JJ receptors_NNS -_: peroxisome_NN proliferator_NN
        activated_VBN receptors_NNS (_( PPARs_NNP )_) ;_: however_RB ,_, it_PRP is_VBZ now_RB becoming_VBG
        evident_JJ that_IN FAs_NNP can_MD affect_VB many_JJ different_JJ genes_NNS either_CC via_IN
        direct_JJ interactions_NNS or_CC indirectly_RB through_IN additional_JJ
        transcription_NN factors_NNS including_VBG hepatic_JJ nuclear-_NN 4_CD α_NN
        (_( HNF-_NNP 4_CD α_NN )_) ,_, nuclear_JJ factor_NN κβ_NN (_( NF-κβ_NNP )_) ,_, retinoid_NN X_NNP receptor_NN α_NN
        (_( RXRα_NNP )_) ,_, sterol_NN regulatory_JJ element_NN binding_JJ protein-_NN 1_CD c_SYM
        (_( SREBP-_NNP 1_CD c_SYM )_) ,_, and_CC liver_NN X_NNP receptors_NNS (_( LXRα_NNP and_CC LXRβ_NNP )_) [_NN 17_CD ]_NN ._.
        Indeed_RB ,_, the_DT enthusiasm_NN for_IN uncovering_VBG the_DT biological_JJ
        pathways_NNS underlying_VBG the_DT beneficial_JJ actions_NNS of_IN LC-PUFA_NNP has_VBZ
        revealed_VBN a_DT story_NN that_WDT is_VBZ increasingly_RB more_RBR complex_JJ than_IN
        originally_RB supposed_VBN [_NN 23_CD ]_NN ,_, thereby_RB making_VBG microarray_NN
        technology_NN an_DT ideal_JJ platform_NN to_TO further_VB decipher_NN the_DT many_JJ
        roles_NNS of_IN these_DT nutritional_JJ lipids_NNS ._.
        In_IN the_DT present_JJ work_NN ,_, mice_NNS were_VBD fed_VBN control_NN diets_NNS
        adequate_JJ in_IN 18_CD :_: 2_CD n_NN 6_CD and_CC 18_CD :_: 3_CD n_NN 3_CD but_CC lacking_VBG LC-PUFA_NNP ;_: or_CC a_DT
        diet_NN enriched_JJ in_IN fungal_NN oil_NN (_( FUNG_NNP )_) enriched_JJ in_IN AA_NN ,_, the_DT n_NN 6_CD
        elongation_NN and_CC desaturation_NN product_NN of_IN 18_CD :_: 2_CD n_NN 6_CD ;_: or_CC a_DT diet_NN
        containing_VBG fish_NN oil_NN (_( FISH_NNP )_) enriched_JJ in_IN 22_CD :_: 6_CD n_NN 3_CD and_CC 20_CD :_: 5_CD n_NN 3_CD ,_,
        the_DT major_JJ n_NN 3_CD LC-PUFA_NNP elongation_NN and_CC desaturation_NN products_NNS
        of_IN 18_CD :_: 3_CD n_NN 3_CD ;_: or_CC a_DT diet_NN containing_VBG both_DT fungal_NN oil_NN and_CC fish_NN
        oil_NN (_( FUNG_NNP +_NN FISH_NNP )_) ._. Thereafter_RB ,_, gene_NN expression_NN profiling_VBG was_VBD
        performed_VBN on_IN two_CD organs_NNS in_IN parallel_JJ with_IN quantitative_JJ
        metabolic_JJ profiling_VBG of_IN a_DT broad_JJ spectrum_NN of_IN liver_NN FAs_NNP ._.
        Tissues_NNPS of_IN interest_NN were_VBD liver_NN ,_, the_DT major_JJ lipid_NN
        metabolizing_VBG tissue_NN ;_: and_CC brain_NN ,_, the_DT major_JJ neurological_JJ
        tissue_NN and_CC principal_JJ site_NN for_IN accumulation_NN and_CC
        functionality_NN of_IN DHA_NNP (_( and_CC other_JJ fish_NN oil_NN components_NNS )_) ._. The_DT
        hippocampus_JJ brain_NN region_NN was_VBD specifically_RB chosen_VBN because_IN of_IN
        its_PRP$ importance_NN in_IN memory_NN and_CC learning_VBG [_NN 24_CD ]_NN ._. Liver_NNP and_CC
        brain_NN are_VBP metabolically_RB connected_VBN organs_NNS as_IN both_DT AA_NN and_CC DHA_NNP
        cross_NN the_DT blood_NN brain_NN barrier_NN via_IN several_JJ possible_JJ
        carriers_NNS ._. Diets_NNP were_VBD fed_VBN for_IN 57_CD days_NNS to_TO study_VB chronic_JJ and_CC
        sustained_VBN alterations_NNS in_IN control_NN of_IN gene_NN expression_NN rather_RB
        than_IN acute_JJ effects_NNS ._.
      
      
        Results_NNS and_CC discussion_NN
        
          Body_NN weight_NN ,_, feed_NN intake_NN ,_, and_CC incorporation_NN of_IN
          dietary_JJ LC-PUFA_NNP into_IN tissue_NN membranes_NNS
          Mice_NNS were_VBD fed_VBN relatively_RB low_JJ fat_JJ diets_NNS to_TO minimize_VB the_DT
          accretion_NN of_IN body_NN fat_JJ and_CC to_TO avoid_VB the_DT confounding_VBG
          effects_NNS that_IN LC-PUFA_NNP -_: rich_JJ diets_NNS are_VBP known_VBN to_TO exert_VB on_IN
          the_DT progression_NN of_IN obesity_NN ._. Body_NN weight_NN and_CC the_DT change_NN in_IN
          body_NN weight_NN (_( d_SYM 58_CD minus_CC d_SYM 1_LS )_) were_VBD not_RB affected_VBN by_IN dietary_JJ
          FA_NNP modulation_NN (_( 
          p_NN =_SYM 0_CD ._. 17_CD )_) ._. Feed_NNP intake_NN data_NNS showed_VBD
          no_DT significant_JJ differences_NNS amongst_IN groups_NNS (_( classic_JJ ANOVA_NNP
          considering_VBG the_DT cages_NNS and_CC diets_NNS as_IN cofactors_NNS ;_: 
          p_NN >_NN 0_CD ._. 05_CD )_) ._. There_EX were_VBD also_RB no_DT
          obvious_JJ differences_NNS in_IN brain_NN and_CC liver_NN weights_NNS (_( 
          p_NN >_NN 0_CD ._. 05_CD )_) ._. By_IN these_DT criteria_NNS ,_,
          differences_NNS in_IN gene_NN expression_NN and_CC metabolic_JJ profiles_NNS
          described_VBD herein_NN were_VBD judged_VBN to_TO be_VB linked_VBN to_TO the_DT FAs_NNP
          present_JJ in_IN FUNG_NNP and_CC FISH_NNP oils_NNS on_IN healthy_JJ ,_, normal_JJ weight_NN
          animals_NNS ._.
          The_DT incorporation_NN of_IN 20_CD :_: 4_CD n_NN 6_CD and_CC 22_CD :_: 4_CD n_NN 6_CD following_VBG
          feeding_NN of_IN the_DT AA-rich_NNP FUNG_NNP diet_NN ,_, and_CC the_DT incorporation_NN
          of_IN 20_CD :_: 5_CD n_NN 3_CD ,_, 22_CD :_: 5_CD n_NN 3_CD ,_, and_CC 22_CD :_: 6_CD n_NN 3_CD following_VBG feeding_NN of_IN the_DT
          EPA_NNP /_NN DHA-rich_NNP FISH_NNP diet_NN ,_, into_IN whole_JJ brain_NN ,_, hippocampal_NN ,_,
          and_CC hepatic_JJ phospholipid_NN (_( PL_NNP )_) pools_NNS (_( Table_NNP 1_LS )_) was_VBD further_JJ
          evidence_NN the_DT diets_NNS were_VBD consumed_VBN ,_, resulting_VBG in_IN
          significant_JJ changes_NNS to_TO PL_NNP acyl_NN composition_NN ._. Fish_NN oil_NN
          feeding_NN is_VBZ well_RB established_VBN to_TO increase_VB n_NN 3_CD LC-PUFA_NNP in_IN
          hepatic_JJ PL_NNP as_RB well_RB as_IN whole_JJ brain_NN PL_NNP [_NN 18_CD ]_NN ;_: whereas_IN
          deficiency_NN of_IN n_NN 3_CD LC-PUFA_NNP can_MD decrease_VB 22_CD :_: 6_CD n-_NN 3_CD in_IN
          hippocampal_NN PL_NNP [_NN 25_CD ]_NN ._. DHA_NNP present_JJ in_IN the_DT brain_NN can_MD be_VB
          formed_VBN from_IN precursors_NNS in_IN the_DT liver_NN or_CC astrocytes_NNS ,_, and_CC
          intact_JJ DHA_NNP passes_VBZ the_DT blood_NN brain_NN barrier_NN via_IN selective_JJ
          transport_NN mechanisms_NNS [_NN 26_CD ]_NN ._. These_DT data_NNS confirm_VBP that_IN
          diets_NNS did_VBD result_NN in_IN actual_JJ increases_NNS in_IN the_DT brain_NN of_IN the_DT
          appropriate_JJ FAs_NNP and_CC set_VBD the_DT stage_NN for_IN interpreting_VBG
          transcriptional_NN responses_NNS observed_VBD in_IN each_DT organ_NN ._.
          Importantly_NNP ,_, our_PRP$ lipid_NN profiling_VBG data_NNS revealed_VBD that_IN
          FUNG_NNP and_CC FISH_NNP FAs_NNP were_VBD not_RB identically_RB incorporated_VBN into_IN
          individual_JJ PL_NNP in_IN the_DT two_CD organs_NNS studied_VBN (_( partly_RB shown_VBN in_IN
          Table_NNP 1_LS )_) ,_, and_CC this_DT may_MD affect_VB subsequent_JJ transcription_NN
          factor_NN signaling_VBG ._. For_IN example_NN ,_, there_EX was_VBD consistently_RB
          more_JJR AA_NN accumulating_VBG in_IN various_JJ hepatic_JJ PL_NNP than_IN in_IN the_DT
          hippocampus_JJ following_NN AA_NN feeding_NN ;_: and_CC more_JJR DHA_NNP
          accumulated_VBN in_IN hepatic_JJ cardiolipin_NN (_( CL_NNP )_) than_IN in_IN
          hippocampal_NN CL_NNP ,_, whereas_IN the_DT reverse_NN was_VBD true_JJ for_IN
          phosphatidylserine_NN /_NN phosphatidylinositol_NN (_( PS_NNP /_NN PI_NNP )_) ._. Thus_RB ,_,
          there_EX are_VBP several_JJ explanations_NNS for_IN why_WRB FUNG_NNP ,_, FISH_NNP ,_, and_CC
          FUNG_NNP +_NN FISH_NNP feeding_NN resulted_VBD in_IN different_JJ transcriptional_NN
          profiles_NNS in_IN liver_NN and_CC hippocampus_JJ ,_, as_IN discussed_VBN
          subsequently_RB ._.
        
        
          Gene_NNP Expression_NNP analysis_NN
          Differentially_NNP expressed_VBD genes_NNS induced_VBN by_IN the_DT dietary_JJ
          treatments_NNS were_VBD selected_VBN using_VBG a_DT limit_NN fold_VB change_NN (_( LFC_NNP )_)
          model_NN ,_, in_IN addition_NN to_TO a_DT more_RBR conventional_JJ confidence_NN
          interval_NN test_NN [_NN 27_CD ]_NN ._. Genes_NNP that_WDT satisfied_VBD the_DT 5_CD %_NN LFC_NNP
          model_NN and_CC which_WDT lay_VBP above_IN the_DT 99_CD ._. 9_CD %_NN confidence_NN interval_NN
          of_IN pooled_VBN replicates_NNS were_VBD selected_VBN as_RB differentially_RB
          expressed_VBD ._. It_PRP should_MD also_RB be_VB noted_VBN that_IN for_IN the_DT liver_NN
          data_NN ,_, inter-individual_JJ variation_NN was_VBD examined_VBN ._. All_DT genes_NNS
          selected_VBN as_RB differentially_RB expressed_VBD using_VBG pooled_VBN data_NNS in_IN
          the_DT liver_NN also_RB laid_VBD outside_IN the_DT 99_CD ._. 0_CD %_NN confidence_NN interval_NN
          when_WRB compared_VBN to_TO individual_JJ mouse_NN variability_NN ,_, thereby_RB
          lending_NN additional_JJ confidence_NN to_TO the_DT selection_NN method_NN
          used_VBN with_IN both_DT the_DT liver_NN and_CC hippocampus_JJ data_NNS ._. According_VBG
          to_TO these_DT criteria_NNS ,_, which_WDT involves_VBZ examining_VBG all_DT possible_JJ
          pair-wise_JJ comparisons_NNS between_IN the_DT four_CD diets_NNS ,_, 329_CD and_CC 356_CD
          differentially_RB expressed_VBD genes_NNS were_VBD selected_VBN in_IN the_DT liver_NN
          and_CC hippocampus_JJ ,_, respectively_RB ._. In_IN the_DT present_JJ document_NN ,_,
          genes_NNS that_WDT are_VBP discussed_VBN are_VBP followed_VBN by_IN parentheses_NNS
          indicating_VBG fold_VB changes_NNS according_VBG to_TO the_DT following_JJ
          convention_NN :_: FUNG_NNP versus_CC control_NN diet_NN ,_, FISH_NNP versus_CC control_NN
          diet_NN ,_, and_CC FUNG_NNP +_NN FISH_NNP versus_CC control_NN diet_NN ,_, 
          e_SYM ._. g_SYM ._. G_NNP 6_CD pc_NN (_( 1_CD ._. 1_LS ,_, 1_CD ._. 6_CD *_NN ,_, -_: 1_CD ._. 9_CD *_NN )_) ._. Those_DT
          fold_VB changes_NNS that_WDT are_VBP significant_JJ by_IN the_DT 5_CD %_NN LFC_NNP model_NN are_VBP
          further_RBR identified_VBN with_IN an_DT asterisk_NN (_( *_NN )_) ._. It_PRP is_VBZ important_JJ
          to_TO note_VB that_IN the_DT nature_NN of_IN the_DT LFC_NNP model_NN allows_VBZ
          differentially_RB expressed_VBN genes_NNS to_TO be_VB selected_VBN based_VBN on_IN
          differences_NNS between_IN the_DT treatments_NNS ,_, and_CC therefore_RB
          explains_VBZ why_WRB some_DT genes_NNS discussed_VBN in_IN the_DT text_NN have_VBP no_DT
          fold_VB changes_NNS marked_VBD with_IN an_DT asterisk_NN (_( as_IN significance_NN was_VBD
          observed_VBN between_IN treatments_NNS and_CC not_RB versus_CC the_DT control_NN
          diet_NN )_) ._. All_DT liver_NN genes_NNS discussed_VBN in_IN the_DT present_JJ
          manuscript_NN are_VBP found_VBN in_IN Figure_NN 1_CD (_( green_JJ dots_NNS )_) and_CC lie_VB
          within_IN the_DT range_NN of_IN validation_NN data_NNS (_( black_JJ squares_NNS )_) ._. The_DT
          high_JJ degree_NN of_IN concordance_NN between_IN RT-PCR_NNP and_CC microarray_NN
          data_NNS (_( 86_CD %_NN -_: reported_VBD in_IN detail_NN elsewhere_RB [_NN 27_CD ]_NN )_)
          establishes_VBZ a_DT certain_JJ level_NN of_IN confidence_NN in_IN the_DT results_NNS
          discussed_VBN throughout_IN this_DT manuscript_NN ._.
          To_TO understand_VB the_DT trends_NNS in_IN transcriptional_NN response_NN
          within_IN and_CC between_IN the_DT two_CD organs_NNS studied_VBN ,_, genes_NNS were_VBD
          annotated_JJ using_VBG GO_NNP classifications_NNS ;_: a_DT dynamic_NN ,_,
          structured_VBN ,_, yet_RB precisely_RB defined_VBN system_NN which_WDT
          characterizes_VBZ genes_NNS based_VBN on_IN defined_VBN categories_NNS of_IN
          molecular_JJ function_NN ,_, biological_JJ process_NN ,_, and_CC cellular_JJ
          component_NN [_NN 28_CD ]_NN ._. Since_IN the_DT GO_NNP classifications_NNS contain_VBP
          several_JJ thousand_CD descriptors_NNS ,_, many_JJ differentially_RB
          expressed_VBD genes_NNS had_VBD a_DT unique_JJ annotation_NN ._. Record_NNP counts_VBZ
          for_IN most_JJS GO_NNP identifiers_NNS were_VBD not_RB high_JJ ,_, although_IN a_DT number_NN
          of_IN significant_JJ trends_NNS were_VBD observable_JJ ._. Venn_NNP diagrams_NNS were_VBD
          constructed_VBN for_IN the_DT top_JJ 10_CD GO_NNP descriptors_NNS for_IN each_DT
          category_NN ,_, according_VBG to_TO record_NN count_NN ,_, to_TO visualize_VB broad_JJ
          transcriptional_NN responses_NNS induced_VBN by_IN dietary_JJ LC-PUFA_NNP
          (_( Figure_NN 2_LS )_) ._. The_DT interpretation_NN of_IN transcriptomic_JJ data_NNS ,_,
          especially_RB that_IN stemming_VBG from_IN a_DT nutritional_JJ study_NN such_JJ as_IN
          this_DT ,_, benefits_NNS greatly_RB from_IN such_JJ a_DT classification_NN system_NN ._.
          The_DT diverse_JJ whole-body_JJ effects_NNS of_IN LC-PUFA_NNP render_VB
          individual_JJ gene_NN interpretation_NN difficult_JJ ;_: however_RB ,_,
          considering_VBG groups_NNS of_IN genes_NNS reveals_VBZ preliminary_JJ
          information_NN concerning_VBG the_DT biological_JJ mechanisms_NNS
          responding_VBG to_TO the_DT addition_NN of_IN dietary_JJ LC-PUFA_NNP ._.
          The_DT GO_NNP analysis_NN and_CC specific_JJ gene_NN expression_NN patterns_NNS
          were_VBD interpreted_VBN to_TO indicate_VB that_IN LC-PUFA-enriched_NNP oils_NNS
          affected_VBD liver_NN metabolism_NN through_IN the_DT regulation_NN of_IN genes_NNS
          directly_RB involved_VBN in_IN FA_NNP metabolism_NN and_CC lipid_NN
          binding_JJ /_NN transport_NN (_( Figure_NN 2_LS )_) ,_, as_RB previously_RB reported_VBD in_IN
          rats_NNS [_NN 18_CD ]_NN ._. When_WRB examining_VBG GO_NNP classifications_NNS for_IN the_DT
          hippocampus_JJ ,_, such_JJ descriptors_NNS as_IN cell_NN signaling_VBG and_CC cell_NN
          cycle_NN control_NN are_VBP seen_VBN in_IN response_NN to_TO dietary_JJ LC-PUFA_NNP ._.
          This_DT result_NN was_VBD expected_VBN ,_, as_IN the_DT two_CD organs_NNS have_VBP very_RB
          different_JJ biochemical_JJ roles_NNS and_CC import_VB dietary_JJ FA_NNP via_IN
          distinctly_RB different_JJ means_NNS ._. The_DT tissue_NN functions_NNS were_VBD
          reflected_VBN in_IN the_DT transcriptomic_JJ profile_NN ._. Although_IN there_EX
          were_VBD relatively_RB few_JJ overlapping_VBG functions_NNS between_IN the_DT two_CD
          organs_NNS ,_, the_DT most_RBS prominent_JJ overlapping_VBG function_NN indicated_VBD
          that_IN LC-PUFA_NNP was_VBD affecting_VBG genes_NNS related_VBN to_TO transcription_NN
          and_CC DNA_NNP /_NN RNA-binding_NNP ._.
        
        
          Hepatic_NNP gene_NN expression_NN analysis_NN and_CC transcription_NN
          factor_NN signatures_NNS
          It_PRP is_VBZ difficult_JJ to_TO interpret_VB transcriptional_NN profiling_VBG
          data_NNS alone_RB ,_, since_IN dimerization_NN ,_, post-translational_JJ
          modifications_NNS ,_, relative_JJ quantities_NNS of_IN co-activators_JJ and_CC
          co-repressors_JJ ,_, and_CC the_DT formation_NN of_IN multiple_JJ
          transcriptional_NN complexes_NNS binding_JJ to_TO common_JJ promoter_NN
          regions_NNS ultimately_RB determines_VBZ the_DT binding_JJ activation_NN
          potential_NN of_IN transcription_NN factors_NNS ._. Nevertheless_RB ,_,
          clustering_VBG analysis_NN of_IN differentially_RB regulated_VBN genes_NNS
          revealed_VBD numerous_JJ genes_NNS known_VBN to_TO be_VB regulated_VBN by_IN specific_JJ
          transcription_NN factors_NNS ,_, thereby_RB enabling_VBG several_JJ
          transcription_NN factor_NN signatures_NNS to_TO be_VB established_VBN ._. These_DT
          signatures_NNS then_RB provide_VBP clues_NNS concerning_VBG the_DT various_JJ
          pathways_NNS through_IN which_WDT FA_NNP may_MD effect_VB gene_NN transcription_NN ._.
          Additionally_RB ,_, FUNG_NNP and_CC FISH_NNP diets_NNS regulated_VBN some_DT
          transcription_NN factors_NNS not_RB (_( Table_NNP 2_LS )_) previously_RB associated_VBN
          with_IN these_DT dietary_JJ oils_NNS ,_, thereby_RB indicating_VBG novel_NN LC-PUFA_NNP
          mediated_JJ molecular_JJ mechanisms_NNS of_IN action_NN ._. These_DT include_VBP :_:
          Spot_NNP 14_CD (_( Thrsp_NNP )_) ,_, transcription_NN factor_NN 7_CD T-_NNP cell_NN specific_JJ
          (_( Tcf_NNP 7_CD )_) ,_, transcription_NN factor_NN 2_CD (_( Tcf_NNP 2_LS )_) ,_, nuclear_JJ
          transcription_NN factor-_NN Y_NNP β_NN (_( NF-Y_NNP β_NN ;_: Nfyb_NNP transcript_NN )_) ,_, D_NNP site_NN
          albumin_NN promoter_NN binding_JJ protein_NN (_( Dbp_NNP )_) ,_, general_JJ
          transcription_NN factor_NN II_NNP (_( Gtf_NNP 2_CD I_PRP )_) ,_, activating_VBG transcription_NN
          factor_NN 5_CD (_( Atf_NNP 5_LS )_) ,_, Msx-interacting-zinc_NNP finger_NN (_( Miz_NNP 1_LS )_) ,_, and_CC
          pre_NN B-_NNP cell_NN leukemia_NN transcription_NN factor_NN 1_CD (_( Pbx_NNP 1_LS )_) ._. In_IN the_DT
          present_JJ work_NN ,_, the_DT focus_NN will_MD be_VB on_IN transcription_NN factors_NNS
          previously_RB identified_VBN as_IN mediators_NNS of_IN LC-PUFA_NNP actions_NNS ,_,
          such_JJ as_IN PPARs_NNP ,_, SREBP_NNP ,_, and_CC HNFs_NNP ._.
        
        
          Hepatic_NNP peroxisome_NN proliferator-activated_JJ receptors_NNS
          (_( PPARs_NNP )_)
          PPARs_NNP are_VBP nuclear_JJ hormone_NN receptors_NNS that_WDT are_VBP activated_VBN
          by_IN micromolar_NN concentrations_NNS of_IN various_JJ FAs_NNP and_CC FA_NNP
          analogues_NNS ,_, such_JJ as_IN fibrates_NNS and_CC thiazolidinediones_NNS [_NN 29_CD ]_NN
          ._. This_DT subfamily_RB can_MD be_VB divided_VBN into_IN three_CD isotypes_NNS ,_,
          designated_VBN PPARα_NNP ,_, PPARδ_NNP and_CC PPARγ_NNP ,_, each_DT with_IN
          tissue-specific_JJ expression_NN ._. PPARs_NNP form_NN heterodimers_NNS with_IN
          retinoid_NN X_NNP receptor_NN (_( RXR_NNP )_) ,_, and_CC interact_NN with_IN the_DT
          peroxisome_NN proliferator_NN response_NN element_NN (_( PPREs_NNP )_) in_IN gene_NN
          promoters_NNS ._. PPREs_NNP are_VBP direct_JJ repeats_VBZ (_( DR_NNP )_) of_IN a_DT
          hexanucleotide_NN sequence_NN AGGTCA_NNP separated_VBN by_IN one_CD
          nucleotide_NN and_CC are_VBP therefore_RB referred_VBN to_TO as_IN a_DT DR-_NNP 1_CD
          response_NN element_NN [_NN 30_CD ]_NN ._. PPARα_NNP and_CC PPARγ_NNP play_VBP critical_JJ
          roles_NNS in_IN the_DT catabolism_NN and_CC storage_NN of_IN FA_NNP ,_, whereas_IN the_DT
          function_NN of_IN PPARδ_NNP is_VBZ less_RBR certain_JJ ._. PPARα_NNP is_VBZ the_DT
          predominant_NN PPAR_NNP subtype_NN expressed_VBD in_IN liver_NN ,_, as_IN confirmed_VBN
          presently_RB ._. The_DT other_JJ two_CD subtypes_NNS were_VBD not_RB likely_RB
          expressed_VBD in_IN the_DT mouse_NN liver_NN ,_, as_IN negative_JJ values_NNS were_VBD
          obtained_VBN with_IN the_DT Affymetrix_NNP software_NN ._. PPARα_NNP is_VBZ reported_VBN
          to_TO regulate_VB genes_NNS involved_VBN in_IN FA_NNP transport_NN ,_, synthesis_NN and_CC
          oxidation_NN ,_, glucose_NN and_CC lipid_NN metabolism_NN ,_, ketogenesis_NNS and_CC
          Δ_NN 5_CD ,_, Δ_NN 6_CD ,_, and_CC Δ_NN 9_CD -_: desaturation_NN [_NN 17_CD ]_NN ._.
          In_IN spite_NN of_IN dramatic_JJ differences_NNS in_IN the_DT expression_NN of_IN
          a_DT variety_NN of_IN PPAR-responsive_NNP genes_NNS ,_, PPAR_NNP gene_NN expression_NN
          itself_PRP was_VBD quite_RB constant_JJ in_IN all_DT mice_NNS analyzed_VBD ,_, as_RB
          previously_RB reported_VBD [_NN 31_CD ]_NN ._. This_DT constancy_NN of_IN PPAR_NNP
          expression_NN indicates_VBZ that_IN differences_NNS in_IN the_DT
          transcription_NN of_IN genes_NNS containing_VBG a_DT PPRE_NNP are_NN likely_JJ due_NN
          to_TO the_DT direct_JJ activation_NN of_IN PPARs_NNP ._. Feeding_NNP our_PRP$ diets_NNS
          affected_VBD various_JJ genes_NNS containing_VBG a_DT PPRE_NNP ,_, with_IN roles_NNS in_IN
          triacylglycerol_NN synthesis_NN (_( mitochondrial_NN
          glycerol-_NN 3_CD -_: phosphate_NN acyltransferase_NN ,_, Gpam_NNP )_) ,_, FA_NNP oxidation_NN
          (_( carnitine_NN palmitoyl_NN transferase_NN ,_, Cpt_NNP 1_CD ;_: dienoyl_NN CoA_NNP
          isomerase_NN ,_, Ech_NNP 1_LS )_) ,_, FA_NNP desaturation_NN (_( stearoyl-coenzyme_JJ A_DT
          desaturase_NN ,_, Scd_NNP 1_CD or_CC Δ_NN 9_CD desaturase_NN )_) ,_, gluconeogenesis_NNS
          (_( cytosolic_JJ phosphoenolpyruvate_NN carboxykinase_NN 1_CD ,_, Pck_NNP 1_CD or_CC
          PEPCK_NNP ;_: glucose-_NN 6_CD -_: phosphatase_NN ,_, G_NNP 6_CD pc_NN )_) ,_, cytochrome_NN p_NN 450_CD
          metabolism_NN (_( Cyp_NNP 4_CD a-_NN 10_CD and_CC -_: 14_CD )_) ,_, FA_NNP transport_NN (_( Cd_NNP 36_CD ;_: FA_NNP
          binding_JJ protein_NN ,_, Fabp_NNP 5_LS )_) ,_, cholesterol_NN metabolism_NN and_CC
          transport_NN (_( apolipoprotein_NN A_DT 4_CD ,_, Apoa_NNP 4_CD ;_: apolipoprotein_NN
          B-_NNP 100_CD ,_, ApoB-_NNP 100_CD )_) ,_, and_CC ketone_NN body_NN formation_NN
          (_( mitochondrial_NN 3_CD -_: hydroxy-_NN 3_CD -_: methylglutaryl-coenzyme_JJ A_DT
          synthase_NN 2_CD ,_, Hmgcs_NNP 2_LS )_) ._.
          Various_JJ genes_NNS involved_VBN in_IN cholesterol_NN metabolism_NN
          (_( microsomal_NN transfer_NN protein_NN ,_, MTP_NNP ;_: apolipoprotein_NN C_NNP 3_CD ,_,
          Apoc_NNP 3_CD ;_: cholesterol_NN 7_CD α_NN hydroxylase_NN ,_, Cyp_NNP 7_CD a_DT 1_LS )_) ,_, carbohydrate_NN
          metabolism_NN (_( pyruvate_NN kinase_NN ;_: facilitative_JJ glucose_NN
          transporter_NN gene_NN ,_, GLUT_NNP 2_LS )_) ,_, and_CC coagulation_NN (_( vitamin_NN K_NNP
          dependent_JJ coagulation_NN factors_NNS VII_NNP ,_, IX_CD ,_, X_NNP )_) have_VBP been_VBN
          previously_RB found_VBN to_TO be_VB induced_VBN by_IN PPARs_NNP [_NN 32_CD ]_NN ,_, but_CC were_VBD
          not_RB transcriptionally_RB regulated_VBN in_IN the_DT present_JJ
          experiment_NN ._.
          A_DT recent_JJ study_NN examined_VBD effects_NNS of_IN PPARα-specific_NNP
          induction_NN in_IN murine_NN livers_NNS using_VBG cDNA_NN microarrays_NNS [_NN 30_CD ]_NN
          ._. Despite_IN the_DT different_JJ strain_NN of_IN mice_NNS examined_VBD
          (_( C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP )_) and_CC the_DT different_JJ genomic_JJ technology_NN utilized_JJ
          for_IN the_DT examination_NN of_IN differentially_RB expressed_VBD genes_NNS
          (_( cDNA_NN microarrays_NNS )_) ,_, several_JJ genes_NNS were_VBD found_VBN
          differentially_RB regulated_VBN in_IN both_DT experiments_NNS ,_, indicating_VBG
          that_IN the_DT PPAR_NNP agonist_NN and_CC LC-PUFA_NNP affect_VBP gene_NN expression_NN
          through_IN similar_JJ pathways_NNS ._. Genes_NNP such_JJ as_IN Cd_NNP 36_CD ,_, Cyp_NNP 2_CD b_SYM 9_CD ,_,
          Hmgcs_NNP 2_CD ,_, and_CC Ech_NNP 1_CD were_VBD induced_VBN more_JJR than_IN 4_CD -_: fold_VB when_WRB
          Wy-_NNP 14_CD ,_, 643_CD (_( a_DT PPARα-specific_NNP agonist_NN )_) was_VBD administered_VBN to_TO
          mice_NNS for_IN 2_CD weeks_NNS ._. These_DT transcripts_NNS were_VBD similarly_RB
          regulated_VBN in_IN the_DT current_JJ study_NN ,_, providing_VBG further_JJ
          indication_NN that_IN many_JJ of_IN the_DT differentially_RB expressed_VBN
          genes_NNS were_VBD likely_JJ PPARα-activated_NNP ._.
          Preliminary_JJ evidence_NN suggests_VBZ preferred_VBN ligands_NNS for_IN
          PPAR_NNP activation_NN are_VBP 18_CD C_NNP and_CC 20_CD C_NNP FAs_NNP ,_, as_IN FAs_NNP shorter_JJR
          than_IN 14_CD C_NNP or_CC longer_JJR than_IN 20_CD C_NNP will_MD not_RB fit_VB correctly_RB into_IN
          the_DT PPAR_NNP binding_JJ pocket_NN and_CC stabilize_VB the_DT AF-_NNP 2_CD helix_NN [_NN 17_CD
          ]_NN ._. The_DT net_JJ effect_NN would_MD be_VB that_IN PPAR_NNP co-activators_JJ are_VBP
          not_RB recruited_VBN to_TO relax_VB nucleosomal_NN DNA_NNP and_CC allow_VB
          transcription_NN machinery_NN to_TO interact_NN with_IN various_JJ promoter_NN
          elements_NNS ._. Therefore_RB DHA_NNP (_( 22_CD :_: 6_CD :_: n_NN 3_LS )_) may_MD require_VB
          retroconversion_NN via_IN β-oxidation_JJ to_TO an_DT 18_CD C_NNP or_CC 20_CD C_NNP
          LC-PUFA_NNP prior_RB to_TO activating_VBG PPARs_NNP [_NN 17_CD 33_CD ]_NN ._. Without_IN the_DT
          use_NN of_IN purified_JJ FA_NNP it_PRP is_VBZ difficult_JJ to_TO distinguish_VB whether_IN
          the_DT DHA_NNP in_IN our_PRP$ fish_NN oil_NN preparation_NN was_VBD retroconverted_JJ
          since_IN the_DT fish_NN oil_NN also_RB provided_VBD the_DT retroconversion_NN
          products_NNS ,_, 20_CD :_: 5_CD n_NN 3_CD and_CC 22_CD :_: 5_CD n_NN 3_CD (_( Table_NNP 3_LS )_) ._. Likewise_RB ,_, AA_NN was_VBD
          not_RB provided_VBN as_IN a_DT pure_JJ FA_NNP component_NN making_VBG comparisons_NNS to_TO
          the_DT control_NN to_TO detect_VB retroconversion_NN difficult_JJ ._. However_RB ,_,
          earlier_JJR work_NN clearly_RB shows_VBZ that_IN both_DT DHA_NNP and_CC AA_NN can_MD be_VB
          retroconverted_JJ to_TO 2_CD carbon_NN shortened_VBN intermediates_NNS ._.
        
        
          Hepatic_NNP sterol_NN regulatory_JJ element-binding_JJ proteins_NNS
          (_( SREBPs_NNP )_)
          SREBPs_NNP are_VBP critically_RB important_JJ basic_JJ helix-loop_JJ helix_NN
          (_( bHLH_NN )_) transcription_NN factors_NNS activated_VBN in_IN response_NN to_TO
          variations_NNS in_IN intracellular_NN cholesterol_NN levels_NNS that_WDT
          induce_VB transcription_NN of_IN genes_NNS with_IN sterol_NN regulatory_JJ
          element_NN (_( SRE_NNP )_) and_CC E-_NNP box_NN containing_VBG promoters_NNS ._. Within_IN the_DT
          SREBP_NNP promoter_NN element_NN ,_, the_DT liver_NN X_NNP receptor_NN
          (_( LXR_NNP )_) -_: responsive_JJ elements_NNS (_( LXRE_NNP )_) may_MD have_VB an_DT important_JJ
          role_NN [_NN 34_CD ]_NN ._. LC-PUFA_NNP may_MD affect_VB SREBP-_NNP 1_CD c_SYM mediated_JJ
          transcription_NN via_IN several_JJ mechanisms_NNS ._. One_CD mechanism_NN is_VBZ to_TO
          antagonize_VB activation_NN of_IN the_DT LXR_NNP receptor_NN leading_VBG to_TO
          fewer_JJR LXR_NNP /_NN RXR_NNP heterodimer_NN complexes_NNS to_TO bind_NN the_DT LXRE_NNP in_IN
          the_DT SREBP-_NNP 1_CD c_SYM promoter_NN and_CC less_JJR SREBP-_NNP 1_CD c-mediated_JJ
          transcription_NN of_IN SRE-containing_NNP genes_NNS [_NN 34_CD ]_NN ._. The_DT PPARα_NNP
          signaling_VBG cascade_NN intertwines_NNS with_IN SREBP_NNP pathways_NNS since_IN
          LC-PUFA_NNP also_RB activate_VBP PPARα_NNP ,_, which_WDT can_MD induce_VB LXRα_NNP
          expression_NN [_NN 17_CD ]_NN ._.
          In_IN the_DT present_JJ experiment_NN ,_, saturated_VBD FA_NNP replaced_VBD AA_NN
          and_CC DHA_NNP to_TO equilibrate_NN total_JJ fat_JJ content_NN ._. Yoshikawa_NNP 
          et_CC al_NN ._. [_NN 34_CD ]_NN found_VBD AA_NN to_TO be_VB more_RBR
          potent_JJ than_IN DHA_NNP (_( saturated_VBD and_CC monounsaturated_JJ being_NN
          ineffective_JJ )_) at_IN inhibiting_VBG activation_NN of_IN SREBP-_NNP 1_CD c_SYM
          promoter_NN and_CC LXRE_NNP enhancer_NN constructs_NNS ,_, induced_VBN by_IN
          co-expression_JJ of_IN LXRα_NNP or_CC -_: β_NN ._. An_DT increase_NN in_IN transcription_NN
          of_IN SREBP-_NNP 1_CD may_MD be_VB associated_VBN with_IN increased_VBN levels_NNS of_IN the_DT
          active_JJ SREBP-_NNP 1_CD protein_NN ._.
          Numerous_JJ hepatic_JJ genes_NNS containing_VBG SRE_NNP promoters_NNS were_VBD
          regulated_VBN by_IN LC-PUFA_NNP in_IN the_DT present_JJ experiments_NNS ,_,
          including_VBG SREBP-_NNP 1_CD itself_PRP (_( consistent_JJ with_IN [_NN 35_CD 36_CD ]_NN )_) ._.
          Also_RB regulated_VBN were_VBD genes_NNS involved_VBN in_IN triacylglycerol_NN
          synthesis_NN (_( Gpam_NNP )_) ,_, FA_NNP synthesis_NN and_CC elongation_NN (_( Acas_NNP 1_CD ,_,
          Acly_NNP ,_, FA_NNP synthase_NN ,_, Spot_NNP 14_CD ,_, Elovl_NNP 2_CD ;_: Elovl_NNP 2_CD may_MD
          speculatively_RB contain_VB an_DT SRE_NNP as_IN described_VBN by_IN Moon_NNP and_CC
          colleagues_NNS [_NN 35_CD ]_NN )_) ,_, FA_NNP desaturation_NN (_( Scd_NNP 1_LS )_) ,_,
          gluconeogenesis_NNS (_( Pck_NNP 1_LS )_) ,_, cytochrome_NN p_NN 450_CD metabolism_NN
          (_( Cyp_NNP 4_CD a-_NN 10_CD and_CC -_: 14_CD )_) ,_, FA_NNP transport_NN (_( Cd_NNP 36_CD )_) ,_, cholesterol_NN
          metabolism_NN and_CC transport_NN (_( Fpps_NNP )_) ,_, and_CC ketone_NN body_NN
          formation_NN (_( mitochondrial_NN Hmgcs_NNP 2_LS )_) ._. It_PRP is_VBZ evident_JJ that_IN
          genes_NNS containing_VBG a_DT PPRE_NNP have_VBP roles_NNS in_IN FA_NNP oxidation_NN but_CC
          not_RB FA_NNP synthesis_NN ,_, whereas_IN the_DT converse_NN is_VBZ true_JJ for_IN genes_NNS
          containing_VBG SRE_NNP promoters_NNS ._.
          Several_JJ genes_NNS that_WDT may_MD contain_VB SRE_NNP promoters_NNS such_JJ as_IN
          SREBP-_NNP 1_CD and_CC Acly_NNP ,_, and_CC Elovl_NNP 2_CD and_CC Cd_NNP 36_CD ,_, were_VBD found_VBN in_IN the_DT
          same_JJ cluster_NN ._. However_RB ,_, similar_JJ to_TO PPRE-containing_NNP genes_NNS ,_,
          not_RB all_DT SRE-containing_NNP genes_NNS co-clustered_JJ ,_, indicating_VBG
          that_IN not_RB all_DT SRE-containing_NNP genes_NNS were_VBD regulated_VBN
          identically_RB by_IN the_DT three_CD LC-PUFA_NNP diets_NNS ._. Overall_RB ,_, the_DT
          number_NN of_IN regulated_VBN genes_NNS with_IN SREs_NNP and_CC PPREs_NNP indicates_VBZ
          the_DT breadth_NN of_IN molecular_JJ responses_NNS to_TO dietary_JJ LC-PUFA_NNP ,_,
          many_JJ of_IN which_WDT appear_VBP to_TO be_VB co-orchestrated_JJ not_RB only_RB by_IN
          these_DT two_CD transcription_NN factors_NNS ,_, but_CC by_IN additional_JJ
          elements_NNS as_RB well_RB ._.
          Hepatic_NNP SREBP-_NNP 1_CD was_VBD down_RB regulated_VBN with_IN FISH_NNP and_CC
          FUNG_NNP +_NN FISH_NNP ,_, but_CC importantly_RB ,_, not_RB affected_VBN with_IN FUNG_NNP (_( -_: 1_CD ._. 1_LS ,_,
          -_: 2_CD ._. 1_LS *_NN ,_, -_: 1_CD ._. 8_CD *_NN )_) ._. Thus_RB ,_, chronic_JJ AA_NN feeding_NN alone_RB does_VBZ not_RB
          appear_VB ,_, in_IN our_PRP$ experiments_NNS ,_, to_TO interact_NN with_IN the_DT SREBP-_NNP 1_CD
          signaling_VBG cascade_NN ._. It_PRP is_VBZ not_RB clear_JJ how_WRB AA_NN is_VBZ handled_VBN
          differently_RB in_IN the_DT liver_NN to_TO prevent_VB its_PRP$ interaction_NN with_IN
          SREBP_NNP ._. The_DT probe_NN set_VBN in_IN the_DT Affymetrix_NNP Murine_NNP 11_CD k_NN chip_NN
          could_MD not_RB differentiate_VB between_IN the_DT -_: 1_CD a_DT and_NN -_: 1_CD c_SYM splicing_VBG
          variants_NNS of_IN SREBP-_NNP 1_CD ._. There_EX was_VBD however_RB high_JJ sequence_NN
          identity_NN (_( 93_CD %_NN )_) between_IN the_DT probe_NN set_VBD sequence_NN and_CC rat_NN
          ADD_NNP 1_CD mRNA_NN ,_, the_DT murine_NN homologue_NN of_IN human_JJ SREBP-_NNP 1_CD c_SYM ._. The_DT
          SREBP-_NNP 1_CD c_SYM /_NN ADD_NNP 1_CD isoform_NN regulates_VBZ transcription_NN of_IN genes_NNS
          involved_VBN in_IN FA_NNP biosynthesis_NNS and_CC desaturation_NN [_NN 37_CD ]_NN ._.
          SREBP-_NNP 1_CD c_SYM ,_, in_IN addition_NN to_TO interacting_VBG with_IN SREs_NNP ,_, binds_NNS
          E-_NNP box_NN containing_VBG promoters_NNS [_NN 38_CD ]_NN ._. E-_NNP box_NN containing_VBG
          promoters_NNS were_VBD not_RB examined_VBN so_IN the_DT current_JJ data_NN analysis_NN
          could_MD have_VB underestimated_VBN SREBP-_NNP 1_CD -_: linked_VBN effects_NNS ._. Some_DT
          E-_NNP box_NN or_CC bHLH_NN binding_JJ factors_NNS activate_VBP the_DT same_JJ genes_NNS as_IN
          SREBP-_NNP 1_CD ._. For_IN example_NN ,_, both_DT upstream_RB stimulating_VBG factor_NN
          (_( USF_NNP ;_: an_DT E-_NNP box_NN binding_JJ factor_NN )_) and_CC SREBP_NNP bind_NN the_DT FA_NNP
          synthase_NN (_( Fasn_NNP )_) E-_NNP box_NN [_NN 38_CD ]_NN ._. Hepatic_NNP Usf_NNP 2_CD transcription_NN
          was_VBD significantly_RB down_RB regulated_VBN with_IN FISH_NNP ,_, but_CC not_RB
          affected_VBN by_IN FUNG_NNP or_CC the_DT combination_NN diet_NN using_VBG
          microarrays_NNS ,_, but_CC this_DT result_NN could_MD not_RB fully_RB be_VB confirmed_VBN
          using_VBG RT-PCR_NNP (_( 1_CD ._. 2_LS ,_, -_: 5_CD ._. 6_CD *_NN ,_, 1_CD ._. 1_CD with_IN microarray_NN ;_: 2_CD ._. 5_CD ,_, -_: 1_CD ._. 1_LS ,_,
          2_CD ._. 0_CD with_IN RT-PCR_NNP )_) ._.
          The_DT NF-Y_NNP transcription_NN factor_NN adds_VBZ further_JJ complexity_NN
          to_TO transcriptional_NN regulation_NN since_IN it_PRP can_MD interact_NN and_CC
          modulate_VBP the_DT expression_NN of_IN SREBP-_NNP 1_CD c_SYM target_NN genes_NNS
          containing_VBG Y-_NNP box_NN motifs_NNS ,_, such_JJ as_IN those_DT found_VBN in_IN Fasn_NNP [_NN 37_CD
          ]_NN ._. Mutating_NNP the_DT NF-Y_NNP binding_JJ site_NN in_IN Fasn_NNP relieved_VBD
          LC-PUFA-induced_NNP Fasn_NNP down_RB regulation_NN [_NN 39_CD ]_NN ._. Nfyb_NNP was_VBD
          differentially_RB expressed_VBN after_IN dietary_JJ LC-PUFA_NNP addition_NN
          (_( 1_CD ._. 8_CD ,_, -_: 1_CD ._. 6_CD ,_, 1_CD ._. 6_CD )_) ._. Although_IN no_DT significant_JJ changes_NNS were_VBD
          observed_VBN between_IN dietary_JJ treatments_NNS and_CC control_NN diet_NN ,_, a_DT
          significant_JJ difference_NN was_VBD observed_VBN between_IN the_DT FUNG_NNP and_CC
          FISH_NNP diets_NNS ._. Thus_RB ,_, LC-PUFA_NNP could_MD have_VB induced_VBN a_DT joint_JJ
          SREBP-_NNP 1_CD c_SYM /_NN NFY_NNP effect_NN on_IN common_JJ promoter_NN elements_NNS ._.
        
        
          Hepatic_NNP nuclear_JJ factors_NNS (_( HNFs_NNP )_)
          Hepatic_NNP nuclear_JJ factors_NNS have_VBP been_VBN recognized_VBN to_TO be_VB
          transcription_NN factors_NNS mediating_VBG the_DT transcription_NN of_IN a_DT
          variety_NN of_IN genes_NNS putatively_RB involved_VBN in_IN energy_NN
          metabolism_NN ._. HNFs_NNP may_MD compete_VB with_IN PPARs_NNP for_IN binding_JJ to_TO
          DR-_NNP 1_CD elements_NNS ._. Thus_RB ,_, LC-PUFA_NNP can_MD activate_VBP PPARα_NNP /_NN RXRα_NNP ,_,
          leading_VBG to_TO displacement_NN of_IN HNF_NNP 4_CD α_NN from_IN PPRE_NNP ;_: or_CC be_VB
          converted_VBN to_TO CoA_NNP derivatives_NNS ,_, which_WDT in_IN turn_NN can_MD suppress_VB
          HNF_NNP 4_CD α_NN transcriptional_NN activity_NN ._. Alternatively_RB ,_, these_DT
          transcription_NN factors_NNS may_MD respond_VB differently_RB to_TO chronic_JJ
          versus_CC acute_JJ administration_NN of_IN LC-PUFA_NNP ._.
          Hnf_NNP 4_CD α_NN was_VBD not_RB differentially_RB regulated_VBN in_IN the_DT current_JJ
          experiment_NN ._. The_DT related_VBN transcription_NN factor_NN HNF_NNP 3_CD γ_NN
          (_( winged_JJ helix_NN protein_NN ,_, fork_VB head_NN ,_, Foxa_NNP 3_LS )_) was_VBD however_RB down_RB
          regulated_VBN -_: 2_CD ._. 0_CD *_NN fold_VB with_IN FUNG_NNP +_NN FISH_NNP ,_, but_CC not_RB with_IN the_DT
          individual_JJ LC-PUFA_NNP ._. HNF_NNP 3_CD γ_NN protein_NN may_MD be_VB involved_VBN in_IN
          etiology_NN of_IN obesity_NN ,_, hyperlipidemia_NN ,_, and_CC diabetes_NN ,_, by_IN
          regulating_VBG glucagon_NN transcription_NN ,_, insulin_NN resistance_NN ,_,
          and_CC pancreatic_JJ γ_NN cell_NN function_NN [_NN 40_CD 41_CD ]_NN ._. To_TO our_PRP$
          knowledge_NN ,_, the_DT regulation_NN of_IN hepatic_JJ HNF_NNP 3_CD γ_NN expression_NN by_IN
          LC-PUFA_NNP has_VBZ not_RB been_VBN previously_RB reported_VBN ._.
          HNF_NNP 3_CD γ-signaling_JJ may_MD regulate_VB transcription_NN of_IN Pck_NNP 1_CD (_( up_RB
          regulated_VBN ca_MD ._. 2_CD *_NN fold_VB with_IN each_DT diet_NN ,_, presently_RB )_) ,_, and_CC
          G_NNP 6_CD pc_NN (_( differentially_RB regulated_VBN in_IN the_DT current_JJ experiment_NN )_)
          [_NN 42_CD ]_NN ._. HNF_NNP 3_CD γ_NN is_VBZ also_RB reported_VBN to_TO increase_VB transcription_NN
          of_IN several_JJ genes_NNS that_WDT were_VBD not_RB differentially_RB regulated_VBN
          in_IN the_DT present_JJ experiment_NN including_VBG ,_, transferrin_NN ,_,
          tyrosine_NN amino_JJ transferase_NN [_NN 43_CD ]_NN ,_, and_CC IPF-_NNP 1_CD /_NN PDX-_NNP 1_CD [_NN 40_CD
          ]_NN ._.
        
        
          Hepatic_NNP fatty_NN acid_NN synthesis_NN
          In_IN the_DT cytoplasm_NN ,_, FA_NNP synthesis_NN is_VBZ controlled_VBN via_IN Acly_NNP ,_,
          acetyl_NN CoA_NNP carboxylase_NN (_( ACC_NNP )_) ,_, and_CC Fasn_NNP ._. The_DT Acly_NNP reaction_NN
          enhances_VBZ FA_NNP synthesis_NN by_IN providing_VBG more_JJR acetyl_NN CoA_NNP and_CC
          NADPH_NNP substrates_NNS and_CC enhancing_VBG ACC_NNP activity_NN ._. The_DT malonyl_NN
          CoA_NNP generated_VBD in_IN the_DT ACC_NNP reaction_NN then_RB inhibits_NNS FA_NNP
          oxidation_NN by_IN reversibly_RB inhibiting_VBG Cpt_NNP 1_CD ._.
          It_PRP has_VBZ previously_RB been_VBN shown_VBN that_IN the_DT Acly_NNP gene_NN in_IN
          human_JJ cultured_JJ hepatic_JJ cells_NNS has_VBZ a_DT regulatory_JJ region_NN from_IN
          -_: 61_CD to_TO -_: 49_CD in_IN the_DT 5_CD '_POS flanking_VBG region_NN similar_JJ to_TO that_DT of_IN
          Fasn_NNP ,_, which_WDT is_VBZ responsive_JJ to_TO insulin_NN and_CC LC-PUFA_NNP [_NN 44_CD ]_NN ._.
          In_IN the_DT present_JJ experiment_NN ,_, there_EX was_VBD coordinated_VBN down_RB
          regulation_NN of_IN both_DT Acly_NNP (_( between_IN -_: 1_CD ._. 8_CD *_NN and_CC -_: 8_CD ._. 9_CD *_NN fold_VB
          regulation_NN for_IN four_CD different_JJ probe_NN sets_NNS )_) and_CC Fasn_NNP
          (_( -_: 1_CD ._. 9_CD *_NN ,_, -_: 1_CD ._. 3_LS ,_, -_: 5_CD ._. 4_LS *_NN ;_: FUNG_NNP and_CC FISH_NNP were_VBD not_RB statistically_RB
          significant_JJ from_IN one_CD another_DT ,_, but_CC each_DT was_VBD significantly_RB
          different_JJ with_IN the_DT combination_NN diet_NN )_) ._. It_PRP is_VBZ intriguing_JJ
          that_IN ,_, in_IN general_JJ ,_, both_DT Acly_NNP and_CC Fasn_NNP were_VBD more_RBR strongly_RB
          down_RB regulated_VBN with_IN the_DT combination_NN diet_NN than_IN the_DT
          individual_JJ LC-PUFA_NNP ._. This_DT synergy_NN represents_VBZ just_RB one_CD of_IN
          the_DT many_JJ unexpected_JJ findings_NNS revealed_VBD with_IN a_DT
          transcriptomic_JJ approach_NN ._. Although_IN ACC_NNP was_VBD not_RB regulated_VBN
          at_IN the_DT transcriptional_NN level_NN ,_, cytoplasmic_JJ citrate_NN
          (_( generated_VBN from_IN the_DT Acly_NNP reaction_NN )_) is_VBZ an_DT allosteric_JJ
          activator_NN of_IN ACC_NNP ,_, so_RB less_RBR cytoplasmic_JJ citrate_NN would_MD lead_VB
          to_TO less_JJR activation_NN of_IN ACC_NNP [_NN 45_CD ]_NN ._. Transcript_NNP levels_NNS of_IN
          hepatic_JJ acetyl_NN CoA_NNP synthetase_NN 1_CD AMP_NNP forming_VBG (_( acetate_NN :_: CoA_NNP
          ligase_NN AMP_NNP forming_VBG ;_: Acas_NNP 1_LS )_) were_VBD consistently_RB down_RB
          regulated_VBN by_IN LC-PUFA_NNP (_( -_: 2_CD ._. 5_LS *_NN ,_, -_: 1_CD ._. 7_CD *_NN ,_, -_: 4_CD ._. 4_LS *_NN )_) ._. This_DT enzyme_NN
          typically_RB has_VBZ specificity_NN for_IN 2_CD -_: 3_CD C_NNP FA_NNP chain_NN lengths_NNS ._. In_IN
          the_DT liver_NN ,_, intestine_NN ,_, adipose_NN ,_, and_CC mammary_JJ gland_NN ,_, the_DT
          cytoplasmic_JJ form_NN synthesizes_NNS acetyl_NN CoA_NNP for_IN lipogenesis_NNS [_NN
          46_CD ]_NN ._. It_PRP is_VBZ regulated_VBN by_IN SREBP-_NNP 1_CD a_DT ,_, -_: 1_CD c-_NN and_CC -_: 2_CD ,_, as_RB well_RB
          as_IN SP_NNP 1_CD and_CC SP_NNP 3_CD binding_JJ to_TO GC-boxes_NNP ;_: the_DT promoter_NN also_RB
          contains_VBZ an_DT E-_NNP box_NN [_NN 47_CD ]_NN ._. It_PRP is_VBZ down_RB regulated_VBN with_IN
          fasting_VBG ,_, and_CC induced_VBD with_IN re-feeding_JJ ;_: such_JJ dietary_JJ
          regulation_NN does_VBZ not_RB exist_VB in_IN SREBP-_NNP 1_CD knockout_NN mice_NNS [_NN 48_CD ]_NN
          ._. More_RBR generally_RB ,_, acyl_NN CoA_NNP synthase_NN is_VBZ reported_VBN to_TO be_VB
          PPARα-activated_NNP [_NN 49_CD ]_NN ._. The_DT observed_VBD down_RB regulation_NN is_VBZ
          consistent_JJ with_IN less_JJR acetyl_NN CoA_NNP available_JJ for_IN the_DT ACC_NNP
          reaction_NN ,_, as_RB well_RB as_IN a_DT plethora_NN of_IN other_JJ reactions_NNS ._.
          Overall_RB ,_, it_PRP is_VBZ plausible_JJ that_IN both_DT FUNG_NNP and_CC FISH_NNP feeding_NN
          decreased_VBD FA_NNP synthesis_NN in_IN the_DT current_JJ experiment_NN ._.
        
        
          Hepatic_NNP FA_NNP oxidaton_NN
          As_IN described_VBD above_IN ,_, Acly_NNP expression_NN (_( and_CC possibly_RB ACC_NNP
          activity_NN )_) was_VBD significantly_RB down_RB regulated_VBN by_IN LC-PUFAs_NNP ,_,
          likely_JJ leading_VBG to_TO less_JJR FA_NNP synthesis_NN ._. Malonyl_NNP CoA_NNP inhibits_NNS
          FA_NNP oxidation_NN by_IN reversibly_RB inhibiting_VBG Cpt_NNP 1_CD ._. Cpt_NNP 1_CD
          transfers_NNS acyl_NN residues_NNS from_IN CoA_NNP to_TO carnitine_NN in_IN the_DT
          intermembrane_NN space_NN of_IN the_DT inner_JJ mitochondrial_NN membrane_NN ,_,
          and_CC has_VBZ a_DT regulatory_JJ role_NN in_IN controlling_VBG hepatic_JJ
          β-oxidation_JJ [_NN 50_CD ]_NN ._. Cpt_NNP 2_CD transfers_NNS carnitinoyl_NN residues_NNS
          to_TO CoA_NNP in_IN the_DT mitochondrial_NN matrix_NN for_IN β-oxidation_JJ ._.
          Carnitine_NNP acetyltransferase_NN (_( Crat_NNP )_) may_MD have_VB the_DT same_JJ role_NN
          as_IN CPT_NNP 2_CD ,_, but_CC with_IN specificity_NN for_IN 2_CD -_: 10_CD C_NNP units_NNS ._.
          Mitochondrial_NNP Cpt_NNP 1_CD (_( 1_CD ._. 8_CD *_NN ,_, 1_CD ._. 4_CD ,_, 1_CD ._. 7_CD *_NN )_) ,_, Cpt_NNP 2_CD (_( 1_CD ._. 6_CD ,_, 1_CD ._. 9_CD *_NN ,_,
          1_CD ._. 7_CD *_NN )_) ,_, and_CC Crat_NNP (_( 1_CD ._. 4_LS ,_, 3_CD ._. 3_CD *_NN ,_, 1_CD ._. 2_LS )_) were_VBD all_DT up_RB regulated_VBN by_IN
          LC-PUFA_NNP ,_, but_CC the_DT three_CD LC-PUFA_NNP were_VBD not_RB identical_JJ in_IN this_DT
          regard_NN ._. For_IN example_NN ,_, Crat_NNP expression_NN was_VBD significantly_RB up_RB
          regulated_VBN 3_CD ._. 3_CD *_NN fold_VB with_IN FISH_NNP treatment_NN ,_, but_CC was_VBD less_RBR
          effected_JJ with_IN FUNG_NNP and_CC the_DT combination_NN diet_NN ._.
          Acyl-_NNP Coenzyme_NNP A_DT dehydrogenase_NN catalyzes_NNS the_DT first_JJ step_NN
          in_IN mitochondrial_NN β-oxidation_JJ ,_, converting_VBG acyl-_NN CoA_NNP to_TO
          2_CD -_: trans-enoyl_JJ CoA_NNP ._. Isoforms_NNP with_IN specificity_NN for_IN short_JJ ,_,
          medium_NN ,_, and_CC long_JJ chain_NN FA_NNP exist_VB ._. Medium-chain_NNP
          acyl-_NN Coenzyme_NNP A_DT dehydrogenase_NN (_( Acadm_NNP )_) was_VBD up_RB regulated_VBN ,_,
          particularly_RB with_IN the_DT combination_NN diet_NN (_( 1_CD ._. 5_LS ,_, 1_CD ._. 3_CD ,_,
          1_CD ._. 7_CD *_NN )_) ._.
          Dienoyl_NNP CoA_NNP isomerase_NN (_( also_RB known_VBN as_IN Δ_NN 3_CD ,_, 5_CD Δ_NN 2_CD ,_, 4_CD dienoyl_NN
          CoA_NNP isomerase_NN ;_: Ech_NNP 1_CD transcripts_NNS )_) converts_VBZ double_JJ bonds_NNS to_TO
          
          trans_NNS bonds_NNS during_IN β-oxidation_JJ of_IN
          LC-PUFA_NNP ._. Ech_NNP 1_CD was_VBD significantly_RB up_RB regulated_VBN with_IN FISH_NNP
          alone_RB (_( 1_CD ._. 1_LS ,_, 1_CD ._. 6_CD *_NN ,_, 1_CD ._. 4_LS )_) ,_, consistent_JJ with_IN the_DT need_NN to_TO
          isomerize_NN numerous_JJ double_JJ bonds_NNS during_IN β-oxidation_JJ ._. It_PRP is_VBZ
          not_RB clear_JJ why_WRB FUNG_NNP did_VBD not_RB also_RB up_RP regulate_VB transcripts_NNS ,_,
          as_IN LC-PUFA_NNP are_VBP generally_RB reported_VBN to_TO up_RB regulate_VB this_DT
          isomerase_NN [_NN 51_CD ]_NN ._. The_DT present_JJ data_NN generally_RB suggest_VBP
          LC-PUFA_NNP increased_VBN FA_NNP oxidation_NN by_IN down_RB regulating_VBG Acly_NNP ;_:
          and_CC up_RP regulating_VBG Cpt-_NNP 1_CD and_CC -_: 2_CD ,_, Ech_NNP 1_CD and_CC Acadm_NNP ._. However_RB ,_,
          FUNG_NNP ,_, FISH_NNP ,_, and_CC FUNG_NNP +_NN FISH_NNP did_VBD not_RB affect_VB regulation_NN of_IN
          these_DT transcripts_NNS identically_RB ._.
        
        
          Hepatic_NNP carbohydrate_NN metabolism_NN
          Phosphoenolpyruvate_NNP carboxykinase_NN (_( Pck_NNP 1_LS )_) is_VBZ the_DT
          rate-limiting_JJ enzyme_NN of_IN gluconeogenesis_NNS ,_, and_CC most_JJS of_IN its_PRP$
          activity_NN is_VBZ regulated_VBN transcriptionally_RB ._. Feeding_NNP of_IN all_DT
          three_CD LC-PUFA_NNP diets_NNS led_VBN to_TO an_DT increase_NN in_IN hepatic_JJ Pck_NNP 1_CD
          transcription_NN ,_, indicating_VBG gluconeogenesis_NNS was_VBD favored_VBN
          over_IN glycolysis_NNS ._. Specifically_RB ,_, four_CD probe_NN sets_NNS with_IN high_JJ
          sequence_NN similarity_NN to_TO rat_VB Pck_NNP 1_CD (_( accession_NN numbers_NNS
          AA_NN 106463_CD ,_, AA_NN 110781_CD ,_, AA_NN 080172_CD ,_, AA_NN 063800_CD )_) demonstrated_VBN
          differential_NN gene_NN expression_NN for_IN the_DT mouse_NN Pck_NNP 1_CD
          homologue_NN ._. The_DT signaling_VBG pathways_NNS affecting_VBG Pck_NNP 1_CD
          transcription_NN are_VBP discussed_VBN in_IN the_DT section_NN "_'' cAMP_NN
          signaling_VBG /_NN links_NNS to_TO carbohydrate_NN metabolism_NN "_'' ._.
          G_NNP 6_CD pc_NN converts_VBZ glucose-_NN 6_CD phosphate_NN to_TO free_VB glucose_NN
          during_IN gluconeogenesis_NNS ._. G_NNP 6_CD pc_NN was_VBD unaffected_JJ with_IN FUNG_NNP ,_,
          significantly_RB up_RB regulated_VBN 1_CD ._. 6_CD *_NN fold_VB with_IN FISH_NNP
          (_( consistent_JJ with_IN up_RB regulated_VBN gluconeogenesis_NNS )_) ,_, but_CC down_RB
          regulated_VBN -_: 1_CD ._. 9_CD *_NN fold_VB with_IN the_DT combination_NN diet_NN (_( 1_CD ._. 1_LS ,_,
          1_CD ._. 6_CD *_NN ,_, -_: 1_CD ._. 9_CD *_NN )_) ._. Rat_NNP G_NNP 6_CD pc_NN has_VBZ HNF_NNP 4_CD α_NN consensus_NN binding_JJ sites_NNS
          [_NN 52_CD ]_NN ._. In_IN HeLa_NNP cells_NNS and_CC HepG_NNP 2_CD hepatoma_NN cells_NNS ,_, PUFA_NNP
          down_RB regulated_VBN G_NNP 6_CD pc_NN ,_, possibly_RB via_IN inhibition_NN of_IN HNF_NNP 4_CD α_NN
          promoter_NN activity_NN [_NN 52_CD ]_NN ._. In_IN our_PRP$ current_JJ mouse_NN
          experiment_NN ,_, the_DT transcriptional_NN effects_NNS of_IN LC-PUFA_NNP on_IN
          G_NNP 6_CD pc_NN may_MD thus_RB have_VB been_VBN HNF_NNP 4_CD α-_NN or_CC PPARα_NNP mediated_JJ ._.
        
        
          Hepatic_NNP cAMP_NN signaling_VBG /_NN links_NNS to_TO carbohydrate_NN
          metabolism_NN
          cAMP_NN is_VBZ an_DT important_JJ signaling_VBG molecule_NN that_WDT can_MD be_VB
          found_VBN in_IN specific_JJ cellular_JJ domains_NNS [_NN 53_CD ]_NN ._. Levels_NNP are_VBP
          controlled_VBN through_IN synthesis_NN via_IN adenylate_NN cyclase_NN ,_, and_CC
          degradation_NN via_IN phosphodiesterases_NNS (_( PDEs_NNP )_) ._. Calmodulin_NNP
          PDEs_NNP (_( CaM-PDEs_NNP )_) are_VBP sensitive_JJ to_TO calmodulin_NN and_CC calcium_NN
          up_RB regulation_NN [_NN 54_CD ]_NN ._. cAMP_NN can_MD then_RB affect_VB cell_NN
          signaling_VBG via_IN interactions_NNS with_IN the_DT regulatory_JJ subunits_NNS
          of_IN cAMP_NN activated_VBN kinases_NNS ,_, including_VBG protein_NN kinase_NN A_DT ,_,
          leading_VBG to_TO their_PRP$ subsequent_JJ activation_NN ,_, and_CC via_IN binding_JJ
          of_IN cAMP_NN response_NN element_NN binding_JJ proteins_NNS (_( CREBs_NNP )_) to_TO cAMP_NN
          response_NN elements_NNS (_( CREs_NNP )_) or_CC cAMP_NN response_NN units_NNS (_( CRU_NNP )_)
          consisting_VBG of_IN CREs_NNP ._.
          In_IN the_DT liver_NN ,_, cAMP_NN regulates_VBZ Pck_NNP 1_CD transcription_NN via_IN
          the_DT binding_JJ of_IN CREB_NNP ,_, as_RB well_RB as_IN CCAAT_NNP /_NN enhancer_NN binding_JJ
          protein_NN (_( C_NNP /_NN EBP_NNP )_) ,_, to_TO the_DT CRU_NNP ._. The_DT Pck_NNP 1_CD promoter_NN can_MD thus_RB
          exist_VB in_IN altered_VBN states_NNS of_IN cAMP_NN responsiveness_NNS ,_, depending_VBG
          on_IN the_DT transcription_NN factors_NNS bound_VBN to_TO CRU_NNP elements_NNS [_NN 55_CD ]_NN
          ._. In_IN hepatocytes_NNS ,_, SREBP-_NNP 1_CD c_SYM can_MD block_VB transcriptional_NN
          induction_NN of_IN cAMP_NN on_IN PEPCK-C_NNP metabolic_JJ action_NN [_NN 56_CD ]_NN
          ._.
          In_IN the_DT present_JJ study_NN ,_, liver_NN Cam-_NNP Pde_NNP 1_CD c_SYM was_VBD not_RB
          regulated_VBN by_IN FUNG_NNP and_CC FISH_NNP feeding_NN alone_RB ,_, but_CC was_VBD
          significantly_RB up_RB regulated_VBN 6_CD ._. 0_CD *_NN fold_VB with_IN FUNG_NNP +_NN FISH_NNP
          together_RB ._. A_DT calcium_NN /_NN calmodulin-dependent_JJ protein_NN kinase_NN 2_CD
          (_( CKII_NNP ;_: Camk_NNP 2_CD b_SYM )_) was_VBD not_RB affected_VBN with_IN FUNG_NNP feeding_NN or_CC the_DT
          combination_NN diet_NN ,_, but_CC was_VBD significantly_RB down_RB regulated_VBN
          -_: 7_CD ._. 6_CD *_NN fold_VB with_IN FISH_NNP alone_RB ._. CKII_NNP is_VBZ a_DT calmodulin_NN target_NN
          in_IN the_DT brain_NN ,_, involved_VBN in_IN synaptic_JJ plasticity_NN ._. In_IN the_DT
          liver_NN ,_, CKII_NNP may_MD be_VB associated_VBN with_IN SAG_NNP protein_NN (_( sensitive_JJ
          to_TO apoptosis_NNS gene_NN )_) and_CC phosphorylate_NN it_PRP ._. SAG_NNP in_IN turn_NN has_VBZ
          a_DT role_NN in_IN preventing_VBG oxidation_NN by_IN inhibiting_VBG cytochrome_NN c_SYM
          release_NN and_CC caspase_NN activation_NN ._. Further_RB ,_, CKII_NNP may_MD
          activate_VBP CPT-_NNP 1_CD via_IN cytoskeletal_NN phosphorylation_NN of_IN
          cytokeratin_NN ._. Thus_RB ,_, an_DT activation_NN of_IN CKII_NNP may_MD lead_VB to_TO
          increased_VB β-oxidation_JJ and_CC antioxidant_NN protection_NN ._. Feeding_NNP
          of_IN all_DT three_CD LC-PUFA_NNP diets_NNS led_VBN to_TO an_DT approximately_RB 2_CD *_NN
          fold_VB increase_NN in_IN hepatic_JJ Pck_NNP 1_CD for_IN each_DT probe_NN set_VBN
          identified_VBN ._.
          Overall_RB ,_, LC-PUFA_NNP may_MD up_RB regulate_VB Pck_NNP 1_CD ,_, the_DT
          rate-limiting_JJ enzyme_NN in_IN gluconeogenesis_NNS ,_, via_IN cAMP-_NN ,_,
          SREBP-_NNP 1_CD -_: and_CC /_NN or_CC PPAR-signaling_NNP [_NN 57_CD ]_NN ._. This_DT has_VBZ the_DT
          overall_JJ effect_NN of_IN limiting_VBG fat_JJ accumulation_NN and_CC shunting_VBG
          metabolic_JJ flux_NN to_TO gluconeogenesis_NNS ._. In_IN a_DT molecular_JJ sense_NN ,_,
          FUNG_NNP and_CC FISH_NNP feeding_NN mimics_VBZ (_( or_CC accentuates_NNS )_) the_DT fasted_JJ
          metabolic_JJ state_NN ._.
        
        
          Hepatic_NNP Cytochrome_NNP p_NN 450_CD metabolism_NN of_IN
          LC-PUFA_NNP
          There_RB are_VBP at_IN least_JJS 17_CD cytochrome_NN p_NN 450_CD gene_NN families_NNS
          (_( Cyps_NNP )_) ,_, with_IN four_CD hepatic_JJ types_NNS (_( Cyps_NNP 1_CD -_: 4_LS )_) that_DT
          metabolize_NN foreign_JJ compounds_NNS and_CC lipophilic_JJ substrates_NNS ,_,
          including_VBG hormones_NNS ,_, FAs_NNP ,_, drugs_NNS and_CC xenobiotics_NNS ._. Cyp_NNP 1_CD
          transcription_NN is_VBZ activated_VBN when_WRB cytosolic_JJ hydrocarbons_NNS
          activate_VBP the_DT Ah_UH receptor_NN which_WDT then_RB translocates_NNS to_TO the_DT
          nucleus_NN and_CC heterodimerizes_NNS with_IN Arnt_NNP ,_, leading_VBG to_TO binding_VBG
          to_TO an_DT upstream_RB xenobiotic_JJ response_NN element_NN on_IN Cyp_NNP 1_CD ._. Cyps_NNP
          2_CD -_: 4_CD are_VBP induced_VBN through_IN nuclear_JJ hormone_NN receptors_NNS ._.
          Phenobarbitol_NNP and_CC phenobarbitol-like_JJ substances_NNS activate_VBP
          CAR-RXR_NNP heterodimers_NNS (_( CAR_NNP ,_, constitutive_JJ androstane_NN
          receptor_NN )_) ,_, that_DT bind_NN DR-_NNP 4_CD response_NN elements_NNS on_IN the_DT Cyp_NNP 2_CD
          promoter_NN ._. Cyps_NNP 3_CD and_CC 4_CD are_VBP activated_VBN by_IN PXR-RXR_NNP (_( PXR_NNP ,_,
          pregnane_NN X_NNP receptor_NN )_) and_CC PPARα-RXR_NNP ,_, respectively_RB ,_, also_RB
          binding_JJ DR-_NNP 4_CD response_NN elements_NNS in_IN both_DT cases_NNS ._.
          Nine_CD hepatic_JJ cytochrome_NN p_NN 450_CD family_NN members_NNS were_VBD
          differentially_RB regulated_VBN by_IN LC-PUFA_NNP (_( Cyp_NNP 1_CD a_DT 2_CD ,_, Cyp_NNP 2_CD a_DT 4_CD ,_,
          Cyp_NNP 2_CD b_SYM 9_CD ,_, Cyp_NNP 3_CD a_DT 11_CD ,_, Cyp_NNP 3_CD a_DT 16_CD ,_, Cyp_NNP 4_CD a_DT 10_CD ,_, Cyp_NNP 4_CD a_DT 14_CD ,_, Cypf_NNP 13_CD ,_, and_CC
          Por_NNP )_) ._. Two_CD broad_JJ clusters_NNS (_( hierarchical_JJ clustering_VBG alone_RB )_)
          and_CC 3_CD specific_JJ clusters_NNS (_( hierarchical-_NN and_CC 
          k_NN -_: means_VBZ clustering_VBG )_) of_IN
          co-expression_JJ exist_VB within_IN this_DT subset_NN ,_, indicating_VBG
          transcriptional_NN co-regulation_JJ (_( Table_NNP 2_LS )_) ._. Furthermore_RB ,_,
          additional_JJ specific_JJ clusters_NNS were_VBD close_RB to_TO each_DT other_JJ ,_,
          indicating_VBG only_RB a_DT fine_NN split_NN in_IN expression_NN behavior_NN
          across_IN diets_NNS ._.
          Cyps_NNP 4_CD a-_NN 10_CD ,_, -_: 12_CD ,_, and_CC -_: 14_CD are_VBP specifically_RB involved_VBN in_IN
          ω_NN /_NN ω-_NN 1_CD FA_NNP hydroxylation_NN [_NN 37_CD ]_NN ._. Cyp_NNP 4_CD a_DT 10_CD (_( 2_CD ._. 7_CD *_NN ,_, 4_CD ._. 7_CD *_NN ,_, 3_CD ._. 0_CD *_NN
          with_IN microarray_NN ;_: 15_CD ._. 0_CD *_NN ,_, 18_CD ._. 8_CD *_NN ,_, 6_CD ._. 8_CD *_NN with_IN RT-PCR_NNP )_) and_CC
          Cyp_NNP 4_CD a_DT 14_CD (_( 8_CD ._. 0_CD *_NN ,_, 19_CD ._. 3_LS *_NN ,_, 2_CD ._. 6_CD )_) were_VBD both_DT up_RB regulated_VBN by_IN
          LC-PUFA_NNP ._. The_DT murine_NN P_NN 450_CD 4_CD a_DT 14_CD is_VBZ highly_RB homologous_RB to_TO rat_VB
          4_CD A_DT 2_CD and_CC 4_CD A_DT 3_CD ._. Rat_NNP 4_CD A_DT 2_CD and_CC 4_CD A_DT 3_CD ,_, and_CC murine_NN 4_CD a_DT 10_CD are_NN
          reported_VBN to_TO ω_NN /_NN ω-_NN 1_CD hydroxylate_NN C_NNP 12_CD :_: 0_CD and_CC 20_CD :_: 4_CD n_NN 6_CD ,_, whereas_IN ,_,
          murine_NN 4_CD a_DT 14_CD hydroxylates_NNS only_RB C_NNP 12_CD :_: 0_CD [_NN 58_CD ]_NN ._. Levels_NNP of_IN
          hydroxylated_JJ FA_NNP were_VBD not_RB examined_VBN ._. Changes_NNS in_IN other_JJ
          hepatic_JJ cytochrome_NN p_NN 450_CD genes_NNS are_VBP included_VBN in_IN Table_NNP
          2_CD ._.
        
        
          Hepatic_NNP desaturation_NN of_IN LC-PUFA_NNP
          As_IN previously_RB noted_VBD ,_, SCD-_NNP 1_CD is_VBZ an_DT important_JJ enzyme_NN
          whose_WP$ transcription_NN is_VBZ mediated_JJ by_IN both_DT PPAR-_NNP and_CC
          SREBP-mediated_NNP signaling_VBG [_NN 59_CD ]_NN ._. SCD-_NNP 1_CD introduces_VBZ 
          cis_NNS double_JJ bonds_NNS at_IN position_NN C_NNP 9_CD in_IN
          FA_NNP chains_NNS ._. It_PRP has_VBZ preferred_VBN substrate_NN specificity_NN for_IN
          C_NNP 18_CD :_: 0_CD ,_, but_CC will_MD also_RB desaturate_NN other_JJ saturated_VBD chain_NN
          lengths_NNS ._. FUNG_NNP +_NN FISH_NNP showed_VBD a_DT significant_JJ down_RB regulation_NN
          of_IN transcripts_NNS (_( -_: 1_CD ._. 1_LS ,_, -_: 1_CD ._. 0_CD ,_, -_: 1_CD ._. 8_CD *_NN with_IN microarray_NN ;_: 2_CD ._. 5_CD *_NN ,_,
          -_: 1_CD ._. 4_LS ,_, -_: 2_CD ._. 7_CD *_NN with_IN RT-PCR_NNP )_) ._. In_IN this_DT instance_NN ,_, the_DT
          microarray_NN indicated_VBD no_DT change_NN with_IN FUNG_NNP ;_: however_RB ,_, RT-PCR_NNP
          indicated_VBD an_DT up_JJ regulation_NN ._. This_DT may_MD be_VB expected_VBN as_IN
          RT-PCR_NNP is_VBZ more_RBR sensitive_JJ than_IN microarrays_NNS ._. It_PRP is_VBZ
          important_JJ to_TO note_VB however_RB ,_, that_IN changes_NNS deemed_VBD
          significant_JJ by_IN the_DT microarray_NN were_VBD also_RB confirmed_VBN to_TO be_VB
          significant_JJ by_IN RT-PCR_NNP ,_, as_IN is_VBZ the_DT case_NN for_IN FUNG_NNP +_NN FISH_NNP
          induced_VBD changes_NNS in_IN Scd_NNP 1_CD ._. The_DT transcriptional_NN changes_NNS in_IN
          Scd_NNP 1_CD expression_NN were_VBD in_IN some_DT cases_NNS consistent_JJ with_IN a_DT
          marker_NN for_IN apparent_JJ decreased_VBD enzymatic_JJ activity_NN ,_, namely_RB
          the_DT ratios_NNS of_IN FA_NNP in_IN hepatic_JJ PL_NNP pools_NNS with_IN a_DT Δ_NN 9_CD double_JJ
          bond_NN /_NN same_JJ FA_NNP without_IN a_DT Δ_NN 9_CD double_JJ bond_NN (_( Table_NNP 4_LS )_) ._. For_IN
          example_NN ,_, in_IN PS_NNP /_NN PI_NNP and_CC phosphatidylethanolamine_NN (_( PE_NNP )_) ,_, the_DT
          ratio_NN of_IN 16_CD :_: 1_CD n_NN 7_CD /_NN 16_CD :_: 0_CD and_CC 18_CD :_: 1_CD n_NN 9_CD /_NN 18_CD :_: 0_CD was_VBD lowest_JJS for_IN the_DT
          FUNG_NNP +_NN FISH_NNP diet_NN ._.
        
        
          Hepatic_NNP elongation_NN of_IN LC-PUFA_NNP
          There_EX are_VBP suggestions_NNS in_IN the_DT literature_NN that_IN FA_NNP
          elongation_NN may_MD also_RB be_VB controlled_VBN by_IN transcription_NN factor_NN
          signaling_VBG ._. The_DT elongase_NN Elovl_NNP 2_CD may_MD contain_VB an_DT SRE_NNP ,_, and_CC
          therefore_RB be_VB under_IN the_DT transcriptional_NN control_NN of_IN SREBP_NNP [_NN
          35_CD ]_NN )_) ._. Due_JJ to_TO observations_NNS in_IN the_DT metabolite_NN data_NN ,_, which_WDT
          suggests_VBZ a_DT repression_NN of_IN elongase_NN activity_NN ,_, the_DT dietary_JJ
          regulation_NN of_IN Elovl_NNP 2_CD and_CC Elovl_NNP 3_CD was_VBD focused_VBN on_IN ._.
          Changes_NNS in_IN genes_NNS with_IN known_VBN elongase_NN activity_NN were_VBD
          examined_VBN ._. The_DT yeast_NN gene_NN Elo_NNP 1_CD is_VBZ associated_VBN with_IN
          elongating_VBG FAs_NNP with_IN 14_CD to_TO 16_CD C_NNP ;_: yet_RB ,_, this_DT activity_NN is_VBZ
          often_RB masked_VBN by_IN cytosolic_JJ FA_NNP synthase_NN activity_NN [_NN 60_CD ]_NN ._.
          Evidence_NN shows_VBZ Elovl_NNP 2_CD elongates_NNS FA_NNP to_TO 24_CD C_NNP ;_: and_CC Elovl_NNP 3_CD
          elongates_NNS FA_NNP to_TO 26_CD C_NNP ,_, with_IN preference_NN for_IN converting_VBG FA_NNP
          from_IN 24_CD C_NNP to_TO 26_CD C_NNP ,_, in_IN yeast_NN [_NN 61_CD ]_NN ._.
          The_DT probe_NN set_VBN for_IN Elovl_NNP 2_CD was_VBD down_RB regulated_VBN ,_,
          particularly_RB with_IN FISH_NNP and_CC the_DT combined_VBN diet_NN (_( -_: 1_CD ._. 3_LS ,_,
          -_: 1_CD ._. 7_CD *_NN ,_, -_: 1_CD ._. 8_CD *_NN )_) ,_, consistent_JJ with_IN some_DT of_IN the_DT lipid_NN data_NN
          described_VBD below_IN ;_: whereas_IN the_DT probe_NN set_VBN for_IN Elovl_NNP 3_CD was_VBD not_RB
          affected_VBN by_IN FUNG_NNP ,_, up_RB regulated_VBN with_IN FISH_NNP ,_, and_CC down_RB
          regulated_VBN ,_, although_IN not_RB significantly_RB ,_, with_IN the_DT
          combination_NN diet_NN (_( -_: 1_CD ._. 2_LS ,_, 1_CD ._. 9_CD *_NN ,_, -_: 1_CD ._. 6_CD )_) ._. An_DT NCBI_NNP BLAST_NN search_NN
          identified_VBD the_DT murine_NN homologue_NN of_IN yeast_NN ELO_NNP 2_CD (_( Elovl_NNP 2_LS )_) to_TO
          be_VB Ssc_NNP 2_CD (_( Sequence_NNP similarity_NN to_TO Cig_NNP 30_CD )_) ,_, predominating_VBG in_IN
          liver_NN and_CC testes_NNS [_NN 62_CD ]_NN ;_: complementation_NN studies_NNS in_IN
          yeast_NN mutants_NNS indicated_VBD the_DT functional_JJ equivalent_NN of_IN ELO_NNP 3_CD
          (_( Elovl_NNP 3_LS )_) is_VBZ Ssc_NNP 1_CD [_NN 35_CD ]_NN ._. Substrates_NNP of_IN mouse_NN Ssc_NNP 2_CD were_VBD
          AA_NN and_CC EPA_NNP (_( DHA_NNP was_VBD not_RB tested_VBN )_) [_NN 35_CD ]_NN ._. Thus_RB ,_, FUNG_NNP and_CC
          FISH_NNP feeding_NN may_MD transcriptionally_RB regulate_VB their_PRP$
          subsequent_JJ conversion_NN to_TO elongated_JJ products_NNS ._.
          Our_PRP$ metabolic_JJ data_NNS showed_VBD evidence_NN that_IN elongase_NN
          activities_NNS may_MD have_VB been_VBN altered_VBN by_IN LC-PUFA_NNP feeding_NN ._.
          There_EX was_VBD reduced_VBN conversion_NN of_IN 18_CD to_TO 16_CD C_NNP FA_NNP following_VBG
          LC-PUFA_NNP feeding_NN ._. Specifically_RB ,_, the_DT ratio_NN of_IN C_NNP 18_CD :_: 0_CD /_NN 16_CD :_: 0_CD in_IN
          phosphatidylcholine_NN (_( PC_NN )_) ,_, PS_NNP /_NN PI_NNP ,_, PE_NNP and_CC ether_NN PE_NNP was_VBD
          decreased_VBN by_IN FISH_NNP (_( Table_NNP 3_LS )_) ._. The_DT ratio_NN of_IN 18_CD :_: 1_CD n_NN 7_CD /_NN 16_CD :_: 1_CD n_NN 7_CD
          in_IN sphingomyelin_NN was_VBD decreased_VBN by_IN FUNG_NNP and_CC FUNG_NNP +_NN FISH_NNP ;_: in_IN
          PC_NN ,_, PE_NNP ,_, and_CC CL_NNP only_RB FUNG_NNP feeding_NN decreased_VBD the_DT
          18_CD :_: 1_CD n_NN 7_CD /_NN 16_CD :_: 1_CD n_NN 7_CD ratio_NN ._. There_EX was_VBD also_RB possible_RB reduced_VBN
          conversion_NN of_IN 20_CD C_NNP to_TO 22_CD C_NNP FA_NNP ,_, and_CC 22_CD C_NNP to_TO 24_CD C_NNP FA_NNP ._. The_DT
          ratios_NNS of_IN 24_CD :_: 0_CD /_NN 22_CD :_: 0_CD in_IN sphingomyelin_NN and_CC PS_NNP /_NN PI_NNP ,_,
          24_CD :_: 1_CD n_NN 9_CD /_NN 22_CD :_: 1_CD n_NN 9_CD in_IN PS_NNP /_NN PI_NNP and_CC CL_NNP ,_, 22_CD :_: 4_CD n_NN 6_CD /_NN 20_CD :_: 4_CD n_NN 6_CD in_IN PC_NN ,_, PE_NNP ,_,
          and_CC CL_NNP ,_, and_CC 22_CD :_: 5_CD n_NN 3_CD /_NN 20_CD :_: 5_CD n_NN 3_CD in_IN PC_NN and_CC PE_NNP ,_, were_VBD all_DT reduced_VBN
          by_IN FISH_NNP ,_, whereas_IN FUNG_NNP had_VBD either_CC a_DT neutral_JJ effect_NN or_CC
          partly_RB reversed_VBD effects_NNS seen_VBN with_IN FISH_NNP (_( with_IN exception_NN of_IN
          CL_NNP 24_CD :_: 1_CD n_NN 9_CD /_NN 22_CD :_: 1_CD n_NN 9_CD ratio_NN )_) ._.
        
        
          Hepatic_NNP Lipid_NNP Transport_NNP of_IN FAs_NNP
          Transcription_NNP factors_NNS such_JJ as_IN PPARs_NNP and_CC SREBPs_NNP are_VBP
          also_RB known_VBN to_TO have_VB an_DT effect_NN on_IN various_JJ lipid_NN transport_NN
          genes_NNS ._. Hepatic_NNP Abca_NNP 1_CD ,_, Abca_NNP 7_CD and_CC Abce_NNP 1_CD were_VBD differentially_RB
          regulated_VBN ;_: however_RB ,_, their_PRP$ roles_NNS in_IN the_DT liver_NN are_VBP not_RB
          precisely_RB known_VBN ._. Several_JJ members_NNS of_IN the_DT ATP-binding_NNP
          cassette_NN (_( ABC_NNP )_) superfamily_RB ,_, such_JJ as_IN Abca_NNP 1_CD ,_, are_VBP induced_VBN
          via_IN PPARγ_NNP and_CC LXRα_NNP activation_NN [_NN 63_CD ]_NN ._. Abca_NNP 1_CD has_VBZ been_VBN
          shown_VBN to_TO play_VB a_DT role_NN in_IN reverse_NN cholesterol_NN pathways_NNS and_CC
          may_MD be_VB linked_VBN to_TO HDL_NNP deficiency_NN in_IN metabolic_JJ syndromes_NNS [_NN
          64_CD ]_NN ._. In_IN macrophages_NNS ,_, 18_CD :_: 2_CD n_NN 6_CD and_CC AA_NN increased_VBD ABCA_NNP 1_CD
          protein_NN degradation_NN without_IN affecting_VBG transcriptional_NN
          levels_NNS [_NN 65_CD ]_NN ._. In_IN the_DT current_JJ study_NN ,_, Abca_NNP 1_CD was_VBD
          significantly_RB decreased_VBN by_IN FUNG_NNP and_CC FISH_NNP ._.
          FA_NNP translocase_NN (_( Cd_NNP 36_CD )_) was_VBD significantly_RB up_RB regulated_VBN
          with_IN FISH_NNP alone_RB (_( -_: 1_CD ._. 1_LS ,_, 2_CD ._. 4_CD *_NN ,_, -_: 1_CD ._. 5_LS )_) ._. Cd_NNP 36_CD co-clustered_JJ
          with_IN E-FABP_NNP ,_, Apoe_NNP ,_, Apoc_NNP 1_CD ,_, and_CC Abce_NNP 1_CD transcript_NN ,_, all_DT
          involved_VBN in_IN FA_NNP and_CC sterol_NN transport_NN ._. CD_NNP 36_CD protein_NN
          mediates_NNS long_JJ chain_NN free_JJ FA_NNP uptake_NN in_IN adipocytes_NNS and_CC
          other_JJ tissues_NNS ,_, including_VBG liver_NN ._. In_IN murine_NN pre-adipocytes_JJ ,_,
          it_PRP is_VBZ transcriptionally_RB up_RB regulated_VBN by_IN long_JJ chain_NN free_JJ
          FAs_NNP via_IN a_DT PPARα-mediated_NNP process_NN [_NN 66_CD ]_NN ._. Approaches_NNP
          using_VBG antisense_NN technology_NN ,_, null_NN mice_NNS ,_, transgenic_JJ mice_NNS ,_,
          and_CC microarrays_NNS revealed_VBD important_JJ additional_JJ roles_NNS of_IN
          CD_NNP 36_CD protein_NN as_IN a_DT receptor_NN for_IN thrombospondin_NN ,_, collagen_NN
          type_NN I_PRP ,_, and_CC oxidized_JJ LDL_NNP on_IN macrophages_NNS [_NN 67_CD ]_NN ._. The_DT up_JJ
          regulation_NN of_IN Cd_NNP 36_CD with_IN FISH_NNP ,_, and_CC antagonism_NN in_IN presence_NN
          of_IN FUNG_NNP ,_, merits_NNS further_JJ study_NN ._.
          FA_NNP binding_JJ proteins_NNS (_( FABPs_NNP )_) are_VBP small_JJ cytosolic_JJ
          proteins_NNS with_IN virtually_RB identical_JJ backbone_NN structures_NNS
          that_WDT facilitate_VBP the_DT solubility_NN and_CC intracellular_NN
          transport_NN of_IN FAs_NNP ._. E-FABP_NNP is_VBZ found_VBN in_IN liver_NN and_CC other_JJ
          organs_NNS [_NN 68_CD ]_NN ,_, but_CC it_PRP has_VBZ been_VBN most_RBS studied_VBN in_IN psoriatic_JJ
          skin_NN lesions_NNS [_NN 69_CD ]_NN where_WRB it_PRP has_VBZ putative_JJ roles_NNS in_IN FA_NNP
          cytoplasmic_JJ transport_NN ,_, skin_NN barrier_NN function_NN and_CC
          keratinocyte_NN differentiation_NN [_NN 70_CD ]_NN ._. Although_IN links_NNS
          between_IN PPARs_NNP and_CC E-FABP_NNP have_VBP not_RB currently_RB been_VBN
          identified_VBN ,_, this_DT gene_NN clustered_VBN with_IN other_JJ known_VBN
          PPAR-affected_NNP genes_NNS suggesting_VBG a_DT possibly_RB important_JJ
          regulatory_JJ link_NN ._. Purified_NNP E-FABP_NNP has_VBZ five_CD fold_VB higher_JJR
          affinity_NN for_IN 18_CD :_: 0_CD ,_, than_IN for_IN 18_CD :_: 1_CD n_NN 9_CD and_CC 20_CD :_: 4_CD n_NN 6_CD (_( 22_CD :_: 6_CD n_NN 3_CD not_RB
          studied_VBN )_) [_NN 69_CD ]_NN ._. Herein_NNP ,_, hepatic_JJ E-FABP_NNP expression_NN
          (_( Fabp_NNP 5_CD transcript_NN )_) was_VBD down_RB regulated_VBN by_IN all_DT three_CD diets_NNS
          (_( -_: 5_CD ._. 5_LS *_NN ,_, -_: 8_CD ._. 4_LS *_NN ,_, -_: 13_CD ._. 6_CD *_NN with_IN microarray_NN ;_: -_: 2_CD ._. 9_CD *_NN ,_, -_: 8_CD ._. 5_LS *_NN ,_,
          -_: 16_CD ._. 4_LS *_NN with_IN RT-PCR_NNP ;_: )_) ._. The_DT significance_NN of_IN this_DT large_JJ
          decrease_NN in_IN hepatic_JJ expression_NN by_IN both_DT FUNG_NNP and_CC FISH_NNP ,_, and_CC
          particularly_RB the_DT combination_NN of_IN the_DT two_CD ,_, is_VBZ a_DT potentially_RB
          important_JJ finding_NN whose_WP$ physiological_JJ consequence_NN must_MD be_VB
          further_RBR investigated_VBN ._. Whether_IN LC-PUFA_NNP induces_VBZ the_DT same_JJ
          decrease_NN in_IN Fabp_NNP 5_CD in_IN psoriatic_JJ skin_NN is_VBZ not_RB known_VBN to_TO our_PRP$
          knowledge_NN ._. N_NNP 3_CD LC-PUFA_NNP ,_, particularly_RB 20_CD :_: 5_CD n_NN 3_CD ,_, are_VBP known_VBN to_TO
          be_VB of_IN clinical_JJ benefit_NN in_IN treating_VBG psoriasis_NNS [_NN 71_CD ]_NN ._.
        
        
          Hepatic_NNP cholesterol_NN metabolism_NN ,_, ketogenesis_NNS ,_, and_CC
          apolipoproteins_NNS
          Mitochondrial_NNP Hmgcs_NNP 2_CD ,_, which_WDT is_VBZ involved_VBN in_IN
          ketogenesis_NNS ,_, was_VBD up_RB regulated_VBN ,_, particularly_RB with_IN the_DT
          combination_NN diet_NN (_( 1_CD ._. 2_LS ,_, 1_CD ._. 3_CD ,_, 1_CD ._. 6_CD *_NN )_) ._. Mitochondrial_NNP Hmgcs_NNP 2_CD
          is_VBZ known_VBN to_TO be_VB induced_VBN by_IN PPARα_NNP activation_NN in_IN experiments_NNS
          with_IN hepatocytes_NNS [_NN 72_CD 73_CD ]_NN ._. The_DT cytosolic_JJ form_NN involved_VBN
          in_IN cholesterol_NN biosynthesis_NNS was_VBD not_RB affected_VBN ._. Fpps_NNP was_VBD
          consistently_RB down_RB regulated_VBN (_( -_: 2_CD ._. 4_LS *_NN ,_, -_: 1_CD ._. 6_CD *_NN ,_, -_: 1_CD ._. 9_CD *_NN )_) across_IN
          diets_NNS ,_, which_WDT could_MD lead_VB to_TO reduced_VBN cholesterol_NN synthesis_NN ;_:
          cholesterol_NN synthesis_NN and_CC plasma_NN cholesterol_NN levels_NNS were_VBD
          not_RB determined_VBN ._. Oils_NNS rich_JJ in_IN DHA_NNP ,_, such_JJ as_IN fish_NN oil_NN ,_, have_VBP
          cholesterol_NN and_CC triacylglycerol_NN lowering_VBG properties_NNS [_NN 74_CD
          ]_NN ._.
          LC-PUFA_NNP altered_VBD expression_NN of_IN various_JJ apolipoproteins_NNS ._.
          Apolipoprotein_NNP C_NNP 1_CD (_( Apoc_NNP 1_LS )_) was_VBD only_RB down_RB regulated_VBN with_IN
          FUNG_NNP alone_RB (_( -_: 1_CD ._. 7_CD *_NN ,_, 1_CD ._. 1_CD ,_, 1_CD ._. 0_CD )_) ._. Apolipoprotein_NNP E_NNP (_( Apoe_NNP )_) was_VBD
          only_RB up_RB regulated_VBN with_IN FISH_NNP alone_RB (_( 1_CD ._. 0_CD ,_, 1_CD ._. 5_CD *_NN ,_, -_: 1_CD ._. 2_LS )_) ._.
          There_EX was_VBD consistent_JJ up_RB regulation_NN with_IN all_DT three_CD LC-PUFA_NNP
          diets_NNS of_IN an_DT EST_NNP (_( expressed_VBD sequence_NN tag_NN )_) highly_RB similar_JJ
          to_TO human_JJ apolipoprotein_NN B-_NNP 100_CD (_( ApoB-_NNP 100_CD )_) precursor_NN (_( 2_CD ._. 1_LS *_NN ,_,
          1_CD ._. 9_CD *_NN ,_, 2_CD ._. 0_CD *_NN )_) ._. Both_DT apolipoprotein_NN C_NNP 2_CD (_( Apoc_NNP 2_CD ;_: -_: 1_CD ._. 3_LS ,_, -_: 1_CD ._. 5_LS *_NN ,_,
          -_: 1_CD ._. 6_CD *_NN )_) and_CC apolipoprotein_NN A_DT 4_CD (_( Apoa_NNP 4_CD ;_: described_VBD in_IN detail_NN
          below_IN )_) were_VBD consistently_RB down_RB regulated_VBN across_IN diets_NNS ._.
          Apoe_NNP and_CC Apoc_NNP 1_CD ,_, and_CC Apoa_NNP 4_CD and_CC Apoc_NNP 2_CD ,_, were_VBD similarly_RB
          co-expressed_JJ /_NN co-clustered_JJ across_IN diets_NNS ._. When_WRB clustered_VBN
          with_IN genes_NNS in_IN the_DT more_RBR general_JJ "_'' transport_NN "_'' category_NN ,_,
          categories_NNS of_IN co-expressed_JJ genes_NNS with_IN underlying_VBG roles_NNS in_IN
          lipid_NN and_CC sterol_NN transport_NN were_VBD evident_JJ ._. For_IN example_NN ,_,
          Apoe_NNP and_CC Apoc_NNP 1_CD co-clustered_JJ with_IN Abce_NNP 1_CD and_CC Cd_NNP 36_CD ;_: and_CC
          Apoa_NNP 4_CD and_CC Apoc_NNP 2_CD co-clustered_JJ with_IN Abca_NNP 1_CD and_CC Fabp_NNP 5_CD ._.
          FUNG_NNP and_CC FISH_NNP alone_RB moderately_RB down_RB regulated_VBN Apoa_NNP 4_CD ,_,
          whereas_IN the_DT combination_NN diet_NN resulted_VBD in_IN a_DT large_JJ down_RB
          regulation_NN (_( -_: 2_CD ._. 6_CD *_NN ,_, -_: 3_CD ._. 2_LS *_NN ,_, -_: 17_CD ._. 2_LS *_NN with_IN microarray_NN ;_: -_: 1_CD ._. 3_LS ,_,
          -_: 3_CD ._. 0_CD ,_, -_: 4_CD ._. 9_CD *_NN with_IN RT-PCR_NNP )_) ._. A_DT similar_JJ trend_NN was_VBD seen_VBN for_IN
          Apoa_NNP 4_CD precursor_NN transcript_NN (_( -_: 3_CD ._. 2_LS *_NN ,_, -_: 4_CD ._. 2_LS *_NN ,_, -_: 9_CD ._. 7_CD *_NN )_) ._. ApoAIV_NNP
          protein_NN is_VBZ an_DT anti-atherogenic_JJ component_NN of_IN high-density_JJ
          lipoprotein_NN (_( HDL_NNP )_) particles_NNS and_CC is_VBZ also_RB found_VBN in_IN very_RB
          low-density_NN lipoproteins_NNS and_CC chylomicrons_NNS [_NN 75_CD ]_NN ._. It_PRP is_VBZ
          involved_VBN in_IN cholesterol_NN absorption_NN ;_: low-density_NN
          lipoprotein_NN (_( LDL_NNP )_) clearance_NN as_IN a_DT cofactor_NN for_IN hepatic_JJ
          lipase_NN ;_: increasing_VBG dolichol_NN acylation_NN ;_: and_CC increasing_VBG PE_NNP ,_,
          but_CC not_RB PC_NN ,_, hydrolysis_NNS ._. FUNG_NNP and_CC FISH_NNP may_MD decrease_VB Apoa_NNP 4_CD
          expression_NN through_IN PPARα_NNP [_NN 76_CD 77_CD ]_NN ,_, and_CC in_IN the_DT current_JJ
          experiment_NN ,_, LC-PUFA_NNP may_MD have_VB affected_VBN PPARα_NNP
          transactivation_NN and_CC signaling_VBG ._. ApoAIV_NNP activity_NN could_MD also_RB
          be_VB affected_VBN by_IN diet_NN induced_VBD structural_JJ changes_NNS to_TO
          membrane_NN PL_NNP in_IN lipoprotein_NN particles_NNS ,_, as_IN Apoa_NNP 4_CD
          intercalates_NNS with_IN PC_NN in_IN model_NN membranes_NNS [_NN 78_CD ]_NN ._. The_DT
          biological_JJ consequences_NNS of_IN reduced_VBN Apoa_NNP 4_CD transcription_NN ,_,
          particularly_RB with_IN the_DT combination_NN diet_NN ,_, merits_NNS further_JJ
          investigation_NN ._. Rodents_NNP fed_VBD low_JJ cholesterol_NN diets_NNS ,_, as_IN in_IN
          the_DT present_JJ study_NN ,_, carry_VB most_JJS of_IN their_PRP$ cholesterol_NN in_IN the_DT
          HDL_NNP fraction_NN ,_, and_CC under_IN these_DT conditions_NNS ,_, fish_NN oil_NN
          feeding_NN reduces_VBZ cholesterol_NN from_IN the_DT HDL_NNP fraction_NN ,_, so_IN the_DT
          above_JJ mentioned_VBN changes_NNS in_IN apolipoproteins_NNS ,_, although_IN
          fascinating_JJ ,_, must_MD be_VB interpreted_VBN within_IN the_DT context_NN of_IN
          the_DT chosen_VBN models_NNS ._.
        
        
          FISH_NNP and_CC FUNG-mediated_NNP effects_NNS in_IN the_DT
          Hippocampus_NNP
          In_IN the_DT present_JJ study_NN ,_, 356_CD differentially_RB expressed_VBD
          genes_NNS were_VBD identified_VBN in_IN the_DT hippocampus_JJ using_VBG a_DT 5_CD %_NN LFC_NNP
          model_NN ._. The_DT trend_NN in_IN the_DT data_NNS was_VBD similar_JJ to_TO that_DT seen_VBN
          with_IN liver_NN data_NNS ,_, as_IN shown_VBN in_IN Figure_NN 1_CD (_( see_VB Materials_NNPS and_CC
          Methods_NNP for_IN details_NNS )_) ._. These_DT data_NNS revealed_VBD that_IN the_DT
          consumption_NN of_IN dietary_JJ oils_NNS led_VBN to_TO differences_NNS in_IN the_DT
          expression_NN of_IN a_DT broad_JJ range_NN of_IN hippocampal_NN genes_NNS that_WDT
          have_VBP been_VBN previously_RB indicated_VBN to_TO be_VB involved_VBN in_IN cell_NN
          signaling_VBG and_CC signal_NN transduction_NN ,_, including_VBG cation_NN
          transport_NN ,_, calcium_NN binding_JJ ,_, protein_NN phosphorylation_NN ,_,
          protein_NN kinases_NNS ,_, and_CC ATP-_NNP and_CC GTP-binding_NNP as_IN revealed_VBN by_IN
          examining_VBG GO_NNP identifiers_NNS across_IN all_DT of_IN the_DT diet-regulated_JJ
          genes_NNS (_( Figure_NN 2_LS )_) ._. In_IN striking_JJ contrast_NN to_TO the_DT liver_NN ,_, a_DT
          number_NN of_IN hippocampal_NN LC-PUFA-induced_NNP differentially_RB
          expressed_VBD genes_NNS had_VBD annotations_NNS suggesting_VBG immune_JJ related_VBN
          functions_NNS ,_, as_RB well_RB as_IN general_JJ defense_NN responses_NNS specific_JJ
          to_TO the_DT hippocampus_JJ ,_, including_VBG :_: "_'' MHC-interacting_NNP proteins_NNS ,_,
          lymphocyte_NN antigens_NNS ,_, immunoglobulins_NNS ,_, and_CC defense_NN
          response_NN ._. "_'' Additionally_RB ,_, there_EX were_VBD numerous_JJ ontological_JJ
          assignments_NNS for_IN genes_NNS which_WDT suggested_VBD dietary_JJ LC-PUFA_NNP
          feeding_NN affected_VBD cell_NN cycle_NN control_NN including_VBG the_DT
          following_JJ categories_NNS :_: "_'' cytoskeleton_NN ,_, cell_NN cycle_NN control_NN ,_,
          and_CC cell_NN cycle_NN regulator_NN "_'' ._.
          In_IN the_DT hippocampus_JJ ,_, dietary_JJ LC-PUFA_NNP activated_VBN a_DT
          different_JJ set_NN of_IN transcription_NN factors_NNS than_IN observed_VBD in_IN
          the_DT liver_NN ,_, including_VBG :_: nuclear_JJ factor_NN of_IN κ_NN light_JJ chain_NN
          gene_NN enhancer_NN in_IN B_NNP cells_NNS 1_CD p_NN 105_CD (_( Nfkb_NNP 1_LS )_) ;_: nescient_NN helix_NN
          loop_NN helix_NN 1_CD (_( Nhlh_NNP 1_LS )_) ;_: E_NNP 2_CD F_NN transcription_NN factor_NN 3_CD (_( E_NNP 2_CD f_SYM 3_LS )_) ;_:
          basic_JJ transcription_NN factor_NN 3_CD (_( Btf_NNP 3_LS )_) ;_: inhibitor_NN of_IN DNA_NNP
          binding_JJ 1_CD (_( Idb_NNP 1_LS )_) ;_: D_NNP site_NN albumin_NN promoter_NN binding_JJ protein_NN
          (_( Dbp_NNP )_) ;_: paired_VBN box_NN gene_NN 9_CD (_( Pax_NNP 9_CD )_) ;_: and_CC the_DT ELK_NNP 1_CD member_NN of_IN
          the_DT ETS_NNP oncogene_NN family_NN ._. Although_IN dietary_JJ LC-PUFA_NNP
          activated_VBN numerous_JJ transcriptional_NN factors_NNS in_IN both_DT liver_NN
          and_CC hippocampus_JJ ,_, it_PRP is_VBZ a_DT noteworthy_JJ difference_NN that_IN the_DT
          transcriptional_NN signatures_NNS for_IN PPAR_NNP ,_, SREBP_NNP ,_, and_CC HNF_NNP could_MD
          not_RB be_VB detected_VBN in_IN the_DT hippocampal_NN dataset_NN ._.
          The_DT interpretation_NN of_IN all_DT 356_CD hippocampal_NN transcripts_NNS
          is_VBZ beyond_IN the_DT scope_NN of_IN the_DT current_JJ manuscript_NN ,_, but_CC all_DT
          raw_JJ data_NN is_VBZ deposited_VBN at_IN the_DT NCBI_NNP gene_NN expression_NN Omnibus_NN
          [_NN 79_CD ]_NN ._. The_DT present_JJ data_NN provides_VBZ evidence_NN that_IN LC-PUFA_NNP
          were_VBD incorporated_VBN into_IN brain_NN and_CC hippocampal_NN tissues_NNS (_( as_RB
          previously_RB discussed_VBN )_) and_CC thereby_RB influenced_VBN novel_NN
          signaling_VBG pathways_NNS via_IN receptor_NN interactions_NNS ._. Some_DT of_IN
          these_DT signaling_VBG pathways_NNS are_VBP highlighted_VBN below_IN ._.
        
        
          Hippocampal_NNP signaling_VBG pathways_NNS affected_VBN by_IN dietary_JJ
          LC-PUFA_NNP
          
            Transthyretin_NNP signaling_VBG
            Thyroid_NNP hormones_NNS including_VBG transthyretin_NN are_VBP
            generally_RB involved_VBN in_IN neuronal_NN proliferation_NN and_CC
            differentiation_NN ,_, and_CC are_VBP required_VBN for_IN normal_JJ
            cytoskeletal_NN assembly_NN ._. Transthyretin_NNP is_VBZ specifically_RB
            involved_VBN in_IN transporting_VBG thyroxine_NN (_( T_NN 4_LS )_) and_CC
            retinol-binding_JJ protein_NN in_IN cerebrospinal_NN fluid_NN and_CC
            brain_NN serum_NN ._. AA_NN has_VBZ been_VBN found_VBN to_TO bind_NN transthyretin_NN
            and_CC inhibit_VB thyroxin_NN associations_NNS [_NN 80_CD ]_NN ._.
            Transthyretin_NNP may_MD also_RB sequester_VB β_NN amyloid_NN ,_, thereby_RB
            having_VBG neuroprotective_JJ properties_NNS ._. Dietary_NNP FISH_NNP had_VBD the_DT
            effect_NN of_IN decreasing_VBG Ttr_NNP ;_: whereas_IN ,_, FUNG_NNP and_CC
            particularly_RB the_DT combination_NN diet_NN ,_, increased_VBD Ttr_NNP (_( 1_CD ._. 6_CD ,_,
            -_: 1_CD ._. 9_CD *_NN ,_, 2_CD ._. 2_CD *_NN )_) ._. Similar_JJ to_TO our_PRP$ findings_NNS in_IN mice_NNS ,_, feeding_NN
            rats_NNS fish_NN oil_NN significantly_RB decreased_VBD Ttr_NNP expression_NN in_IN
            whole_JJ brain_NN 2_CD ._. 9_CD fold_VB [_NN 18_CD ]_NN ._. Interestingly_RB ,_, feeding_NN of_IN
            
            Ginkgo_NNP biloba_NN extract_NN (_( publicized_VBN
            to_TO affect_VB mental_JJ function_NN )_) in_IN mice_NNS increased_VBD
            hippocampal_NN Ttr_NNP [_NN 81_CD ]_NN ._. Levels_NNP of_IN transthyretin_NN ,_, and_CC
            associations_NNS of_IN transthyretin_NN with_IN thyroxine_NN and_CC
            retinol-binding_JJ protein_NN should_MD be_VB assessed_VBN in_IN future_JJ
            LC-PUFA_NNP feeding_NN experiments_NNS ._.
          
          
            5_LS -_: hydroxytryptamine_NN signaling_VBG
            Dietary_NNP LC-PUFA_NNP may_MD affect_VB 5_CD -_: hydroxytryptamine_NN
            (_( serotonin_NN ,_, 5_CD -_: HT_NNP )_) signaling_VBG ._. Specifically_RB ,_, 20_CD :_: 4_CD 
            N_NNP -_: acylethanolamine_NN can_MD displace_VB
            binding_JJ of_IN ligands_NNS to_TO HT_NNP receptors_NNS [_NN 82_CD ]_NN ,_, and_CC
            displace_VB 5_CD -_: HT_NNP 
            3_CD receptor_NN currents_NNS [_NN 83_CD ]_NN ,_, and_CC we_PRP
            have_VBP previously_RB reported_VBN that_IN dietary_JJ AA_NN feeding_NN
            increased_VBD whole_JJ brain_NN 20_CD :_: 4_CD 
            N_NNP -_: acylethanolamine_NN ,_, as_IN a_DT
            separate_JJ component_NN of_IN the_DT present_JJ work_NN [_NN 84_CD ]_NN ._. In_IN the_DT
            present_JJ work_NN ,_, dietary_JJ FUNG_NNP and_CC FISH_NNP ,_, alone_RB or_CC together_RB ,_,
            increased_VBD Htr_NNP 4_CD receptor_NN levels_NNS (_( 6_CD ._. 5_LS *_NN ,_, 3_CD ._. 8_CD ,_, 4_CD ._. 4_LS )_) ._. 5_LS -_: HT_NNP 
            4_CD receptor_NN (_( Htr_NNP 4_CD transcript_NN )_)
            increases_NNS in_IN expression_NN have_VBP been_VBN shown_VBN to_TO augment_VB
            hippocampal_NN acetylcholine_NN outflow_NN ,_, thereby_RB affecting_VBG
            cognitive_JJ processes_VBZ [_NN 85_CD ]_NN ._.
          
          
            Alpha-_NNP 2_CD ,_, 8_CD -_: sialyltransferase_NN
            Hippocampal_NNP α-_NN 2_CD ,_, 8_CD -_: sialyltransferase_NN (_( Siat_NNP 8_CD e_SYM )_) was_VBD
            down_RB regulated_VBN with_IN FISH_NNP and_CC the_DT combination_NN diet_NN ,_, but_CC
            not_RB with_IN FUNG_NNP ;_: difference_NN relative_JJ to_TO control_NN was_VBD only_RB
            significant_JJ for_IN the_DT combination_NN diet_NN (_( 1_CD ._. 6_CD ,_, -_: 2_CD ._. 6_CD ,_,
            -_: 6_CD ._. 4_LS *_NN )_) ._. Hippocampal_NNP protein_NN kinase_NN Cδ_NNP (_( Prkcd_NNP )_) was_VBD
            slightly_RB down_RB regulated_VBN with_IN the_DT three_CD LC-PUFA_NNP diets_NNS
            (_( -_: 1_CD ._. 6_CD ,_, -_: 1_CD ._. 3_LS ,_, -_: 1_CD ._. 8_CD *_NN )_) ._. PUFA_NNP feeding_NN can_MD influence_VB PKC_NNP
            activity_NN [_NN 86_CD ]_NN and_CC one_CD mechanism_NN of_IN action_NN may_MD be_VB via_IN
            generation_NN of_IN unique_JJ diacylglycerol_NN molecular_JJ species_NNS [_NN
            87_CD ]_NN ._.
            Alpha-_NNP 2_CD ,_, 8_CD -_: linked_VBN disialic_JJ acid_NN residues_NNS are_VBP found_VBN in_IN
            glycoproteins_NNS [_NN 88_CD ]_NN ._. During_IN learning_VBG ,_, there_EX is_VBZ a_DT
            transient_JJ increase_NN in_IN neuronal_NN polysialyation_NN in_IN the_DT
            dentate_NN gyrus_JJ of_IN the_DT hippocampus_JJ ._. This_DT has_VBZ been_VBN
            associated_VBN with_IN selective_JJ retention_NN and_CC /_NN or_CC elimination_NN
            of_IN synapses_NNS that_WDT are_VBP transiently_RB overproduced_JJ during_IN
            memory_NN consolidation_NN [_NN 89_CD ]_NN ._. In_IN rat_NN hippocampus_JJ ,_,
            during_IN development_NN ,_, PKCδ_NNP can_MD negatively_RB regulate_VB
            polysialyltransferase_NN activity_NN and_CC neural_NN cell_NN adhesion_NN
            molecule_NN (_( NCAM_NNP )_) polysialylation_NN state_NN [_NN 89_CD ]_NN ._. NCAM_NNP is_VBZ
            implicated_VBN in_IN neural_NN differentiation_NN and_CC cellular_JJ
            plasticity_NN [_NN 90_CD ]_NN ._. Our_PRP$ observed_JJ decrease_VB in_IN Prkcd_NNP
            expression_NN may_MD have_VB affected_VBN hippocampal_NN
            polysialyltransferase_NN activity_NN ._. It_PRP is_VBZ not_RB known_VBN if_IN
            Prkcd_NNP regulates_VBZ expression_NN of_IN Siat_NNP 8_CD e_SYM ._.
          
          
            Proopiomelanocortin_NNP (_( POMC_NNP )_)
            POMC_NNP is_VBZ a_DT hypothalamic_JJ neuropeptide_NN ,_, and_CC a_DT target_NN
            for_IN leptin_NN ._. POMC_NNP is_VBZ cleaved_JJ post-translationally_JJ
            producing_NN bioactive_JJ peptides_NNS (_( adrenocorticotrophin_NN ,_,
            β-endorphin_JJ and_CC α-_NN ,_, β-_NN and_CC γ-melanocyte_JJ stimulating_VBG
            hormones_NNS )_) that_DT interact_NN with_IN neurons_NNS expressing_VBG
            melanocortin_NN receptors_NNS ,_, leading_VBG to_TO appetite_NN suppression_NN
            [_NN 91_CD ]_NN ._. Feeding_NNP high_JJ fat_JJ diets_NNS is_VBZ known_VBN to_TO increase_VB
            Pomc_NNP expression_NN [_NN 92_CD ]_NN ._. Herein_NNP ,_, FUNG_NNP feeding_NN resulted_VBD
            in_IN a_DT 6_CD ._. 0_CD *_NN fold_VB increase_NN in_IN hippocampal_NN Pomc_NNP ,_, whereas_IN
            FISH_NNP and_CC the_DT combination_NN diet_NN had_VBD smaller_JJR ,_,
            non-statistically_JJ significant_JJ effects_NNS (_( 6_CD ._. 0_CD *_NN ,_, 1_CD ._. 6_CD ,_, 1_CD ._. 4_LS )_) ._.
            The_DT physiological_JJ effect_NN of_IN potentially_RB increasing_VBG POMC_NNP
            protein_NN with_IN FUNG_NNP feeding_NN is_VBZ not_RB known_VBN ._. As_IN a_DT next_JJ step_NN ,_,
            levels_NNS of_IN POMC_NNP protein_NN and_CC downstream_JJ POMC_NNP peptides_NNS
            should_MD be_VB quantified_VBN
          
        
      
      
        Conclusions_NNP and_CC key_JJ findings_NNS
        The_DT molecular_JJ effects_NNS of_IN dietary_JJ fish_NN oil_NN fed_VBN in_IN
        reasonable_JJ quantities_NNS over_IN prolonged_JJ periods_NNS has_VBZ been_VBN found_VBN
        in_IN humans_NNS and_CC animals_NNS to_TO be_VB related_VBN to_TO alterations_NNS in_IN
        health_NN outcome_NN ._. In_IN the_DT present_JJ study_NN ,_, mice_NNS were_VBD fed_VBN
        relevant_JJ quantities_NNS of_IN fish_NN oil_NN and_CC AA_NN rich_JJ fungal_NN oils_NNS and_CC
        the_DT responses_NNS were_VBD studied_VBN in_IN murine_NN liver_NN and_CC hippocampus_JJ
        using_VBG a_DT combined_VBN gene_NN expression-_NN and_CC lipid-profiling_JJ
        strategy_NN ._. The_DT simple_JJ addition_NN of_IN these_DT oils_NNS to_TO the_DT habitual_NN
        diet_NN of_IN mice_NNS influenced_VBD hundreds_NNS of_IN gene_NN products_NNS [_NN 79_CD ]_NN ._.
        Furthermore_RB ,_, in_IN a_DT striking_JJ number_NN of_IN examples_NNS ,_, inter-diet_JJ
        (_( FUNG_NNP vs_NNS ._. FISH_NNP vs_NNS ._. FUNG_NNP +_NN FISH_NNP )_) and_CC inter-organ_JJ differences_NNS
        in_IN the_DT transcriptional_NN profile_NN were_VBD observed_VBN ,_, indicating_VBG
        that_IN the_DT predominant_NN bioactive_JJ FAs_NNP in_IN fish_NN oil_NN (_( 20_CD :_: 5_CD n_NN 3_CD ,_,
        22_CD :_: 5_CD n_NN 3_CD and_CC 22_CD :_: 6_CD n_NN 3_LS )_) and_CC AA_NN enriched_JJ fungal_NN oil_NN (_( 20_CD :_: 4_CD n_NN 6_CD )_) do_VBP
        not_RB affect_VB gene_NN transcription_NN identically_RB in_IN the_DT two_CD organs_NNS
        studied_VBN ._.
        Hepatic_NNP gene_NN transcriptional_NN profiles_NNS and_CC ontology_NN
        classifications_NNS indicated_VBD that_DT fish_NN oil_NN LC-PUFA_NNP likely_RB
        increased_VBD FA_NNP β-oxidation_JJ and_CC gluconeogenesis_NNS ,_, and_CC decreased_VBD
        FA_NNP synthesis_NN ._. Furthermore_RB ,_, the_DT transcriptional_NN profile_NN
        observed_VBD indicated_VBN that_IN these_DT LC-PUFA_NNP regulated_VBN hepatic_JJ
        energy_NN processes_VBZ through_IN the_DT tight_JJ coordination_NN of_IN several_JJ
        critical_JJ transcriptional_NN factors_NNS ._. Feeding_NNP both_DT LC-PUFA_NNP
        containing_VBG oils_NNS mimicked_JJ (_( or_CC accentuated_JJ )_) the_DT fasted_JJ
        metabolic_JJ state_NN ,_, confirming_VBG this_DT aspect_NN of_IN the_DT beneficial_JJ
        health_NN effects_NNS of_IN dietary_JJ LC-PUFA_NNP for_IN both_DT normal_JJ and_CC
        clinical_JJ populations_NNS ,_, and_CC even_RB household_NN pets_NNS ._.
        These_DT same_JJ conclusions_NNS regarding_VBG energy_NN expenditure_NN were_VBD
        reached_VBN in_IN experiments_NNS assessing_VBG enzymatic_JJ activities_NNS ,_, and_CC
        transcriptional_NN changes_NNS in_IN rat_NN liver_NN using_VBG Northern_NNP blots_NNS ,_,
        where_WRB fish_NN oil_NN feeding_NN :_: increased_VBN palmitoyl_NN CoA_NNP
        mitochondrial_NN and_CC peroxisomal_NN oxidation_NN rate_NN ;_: increased_VBN
        Cpt_NNP 1_CD ,_, Cpt_NNP 2_CD ,_, Δ_NN 3_CD ,_, Δ_NN 2_CD -_: enoyl_NN CoA_NNP isomerase_NN ,_, and_CC Ech_NNP 1_CD
        expression_NN and_CC activity_NN ;_: and_CC decreased_VBD expression_NN and_CC
        activity_NN of_IN FA_NNP synthase_NN ,_, malic_JJ enzyme_NN ,_, glucose_NN 6_CD -_: phosphate_NN
        dehydrogenase_NN ,_, and_CC pyruvate_NN kinase_NN ,_, compared_VBN to_TO palm_VB and_CC /_NN or_CC
        safflower_NN oil_NN feeding_NN [_NN 93_CD ]_NN ._. Likewise_RB ,_, in_IN rat_NN white_JJ
        retroperitoneal_NN adipose_NN tissue_NN ,_, fish_NN oil_NN feeding_NN also_RB
        decreased_VBD Fasn_NNP expression_NN [_NN 94_CD ]_NN ._. Intriguingly_NNP ,_, the_DT
        hormone_NN leptin_NN ,_, which_WDT also_RB acts_VBZ through_IN SREBP-_NNP 1_CD and_CC PPARα_NNP ,_,
        affected_VBD many_JJ transcripts_NNS similarly_RB to_TO LC-PUFA_NNP (_( 
        e_SYM ._. g_SYM ._. ,_, leptin_NN decreased_VBD Gpam_NNP and_CC
        Apoa_NNP 4_CD transcripts_NNS ;_: and_CC up_RB regulated_VBN Ech_NNP 1_CD ,_, mitochondrial_NN
        Hmgcs_NNP 2_CD ,_, and_CC Cyp_NNP 4_CD a_DT 14_CD transcripts_NNS [_NN 95_CD ]_NN ._.
        Chronic_NNP feeding_NN of_IN fish_NN and_CC AA-enriched_NNP fungal_NN oils_NNS
        broadly_RB affected_VBN genes_NNS regulated_VBN by_IN PPARα_NNP ,_, HNFα_NNP ,_, and_CC
        SREBP-_NNP 1_CD in_IN the_DT liver_NN ;_: transcription_NN factors_NNS implicated_VBN in_IN
        lipid_NN metabolism_NN as_RB well_RB as_IN other_JJ processes_NNS ._. Only_RB with_IN
        future_JJ studies_NNS in_IN which_WDT PPAR-specific_NNP agonists_NNS and_CC
        antagonists_NNS are_VBP included_VBN ,_, along_IN with_IN receptor_NN antagonists_NNS ,_,
        will_MD the_DT precise_JJ role_NN of_IN PPAR-signaling_NNP in_IN response_NN to_TO
        LC-PUFA_NNP feeding_NN be_VB elucidated_JJ ._. The_DT overlapping_VBG
        actions_NNS /_NN effects_NNS of_IN these_DT various_JJ transcription_NN factors_NNS
        present_VB a_DT challenge_NN that_WDT will_MD require_VB tools_NNS ,_, such_JJ as_IN
        genomics_NNS and_CC metabolomics_NNS ,_, to_TO provide_VB a_DT stepping_VBG stone_NN
        towards_IN the_DT complete_JJ understanding_NN of_IN LC-PUFA_NNP
        metabolism_NN ._.
        There_EX were_VBD striking_JJ differences_NNS in_IN the_DT genes_NNS and_CC
        transcriptional_NN factors_NNS activated_VBN by_IN LC-PUFA_NNP in_IN the_DT liver_NN
        and_CC hippocampus_JJ ,_, despite_IN these_DT organs_NNS being_VBG metabolically_RB
        linked_VBN ,_, as_IN AA_NN and_CC DHA_NNP cross_NN the_DT blood_NN brain_NN barrier_NN ._. There_RB
        are_VBP at_IN least_JJS three_CD reasons_NNS for_IN these_DT inter-organ_JJ
        differences_NNS ._. Firstly_NNP ,_, the_DT dietary_JJ FAs_NNP were_VBD not_RB identically_RB
        incorporated_VBN into_IN both_DT tissues_NNS ,_, as_IN indicated_VBN by_IN tissue_NN
        lipid_NN profiling_VBG ._. Secondly_RB ,_, different_JJ transcription_NN factors_NNS
        exist_VBP and_CC were_VBD activated_VBN in_IN the_DT two_CD organs_NNS ,_, which_WDT would_MD
        affect_VB downstream_JJ signaling_VBG ._. Thirdly_NNP ,_, there_EX is_VBZ the_DT
        possibility_NN ,_, that_IN even_RB when_WRB the_DT same_JJ transcription_NN factors_NNS
        were_VBD activated_VBN in_IN both_DT organs_NNS ,_, factors_NNS including_VBG
        dimerization_NN partners_NNS ,_, multiple_JJ binding_JJ of_IN various_JJ
        transcription_NN factors_NNS ,_, post-translational_JJ modifications_NNS ,_,
        and_CC signaling_VBG kinetics_NNS could_MD affect_VB the_DT transcriptional_NN
        profile_NN ._.
        Currently_RB ,_, nutritional_JJ FA_NNP recommendations_NNS are_VBP made_VBN
        largely_RB by_IN examining_VBG levels_NNS of_IN key_JJ LC-PUFA_NNP in_IN plasma_NN ;_: and_CC
        less_RBR often_RB ,_, red_JJ blood_NN cells_NNS ,_, platelets_NNS ,_, and_CC biopsied_JJ
        tissue_NN ._. Transcriptional_NNP gene_NN profiles_NNS have_VBP not_RB been_VBN
        considered_VBN in_IN making_VBG such_JJ recommendations_NNS ._. The_DT present_JJ work_NN
        convincingly_RB shows_VBZ the_DT potential_JJ importance_NN of_IN examining_VBG
        transcriptional_NN profiles_NNS in_IN addition_NN to_TO FA_NNP profiles_NNS ;_: and_CC
        the_DT importance_NN of_IN examining_VBG more_JJR than_IN one_CD tissue_NN ,_, in_IN making_VBG
        such_JJ LC-PUFA_NNP nutritional_JJ and_CC clinical_JJ recommendations_NNS ._.
      
      
        Materials_NNS and_CC Materials_NNPS
        
          Experimental_NNP diets_NNS
          All_DT diets_NNS contained_VBD 90_CD %_NN fat-free_JJ AIN_NNP 93_CD G_NNP rodent_NN diet_NN in_IN
          powder_NN form_NN (_( Lot_NN 9350_CD -_: 5_CD ,_, Dyets_NNP ,_, Inc_NNP ._. ,_, Bethlehem_NNP ,_, PA_NNP )_) ,_,
          0_CD ._. 4_CD %_NN milk_NN fat_JJ ,_, 1_CD ._. 2_CD %_NN palm_NN olein_NN ,_, 1_CD ._. 9_CD %_NN Trisun_NNP sunflower_NN
          oil_NN ,_, 1_CD ._. 5_CD %_NN soybean_NN oil_NN and_CC 2_CD ._. 1_CD -_: 5_CD ._. 1_LS %_NN medium_NN chain_NN
          triacylglycerol_NN oil_NN (_( all_DT of_IN the_DT above_JJ ingredients_NNS except_IN
          the_DT AIN_NNP 93_CD G_NNP were_VBD from_IN Nestlé_NNP affiliated_VBN companies_NNS )_) (_( Tables_NNP
          5_CD and_CC 6_CD )_) ._. Part_NN of_IN the_DT medium_NN chain_NN triacylglycerol_NN oil_NN in_IN
          control_NN diet_NN was_VBD replaced_VBN with_IN :_: 1_CD ._. 1_CD %_NN fungal_NN oil_NN
          (_( providing_VBG 0_CD ._. 5_CD dietary_JJ wt_NN %_NN AA_NN and_CC 1_CD ._. 0_CD en_IN %_NN )_) in_IN the_DT FUNG_NNP
          diet_NN ;_: 1_CD ._. 9_CD %_NN fish_NN oil_NN (_( providing_VBG 0_CD ._. 5_CD dietary_JJ wt_NN %_NN DHA_NNP and_CC
          1_CD ._. 0_CD en_IN %_NN )_) in_IN the_DT FISH_NNP diet_NN ;_: and_CC 1_CD ._. 1_CD %_NN fungal_NN oil_NN and_CC 1_CD ._. 9_CD %_NN
          fish_NN oil_NN in_IN the_DT combined_VBN FUNG_NNP +_NN FISH_NNP diet_NN ._. The_DT levels_NNS of_IN AA_NN
          and_CC DHA_NNP chosen_VBN were_VBD similar_JJ to_TO that_DT previously_RB shown_VBN in_IN
          rats_NNS to_TO affect_VB neurotransmitter_NN levels_NNS and_CC behavior_NN [_NN 96_CD
          ]_NN ;_: and_CC were_VBD not_RB excessively_RB high_JJ ,_, being_VBG 2_CD -_: 3_CD fold_VB higher_JJR
          than_IN that_DT recommended_VBD for_IN human_JJ babies_NNS who_WP have_VBP a_DT slower_JJR
          Δ_NN 6_CD desaturase_NN activity_NN than_IN rodents_NNS ._. Food_NNP was_VBD maintained_VBN
          at_IN -_: 80_CD °_NN C_NNP in_IN daily_JJ aliquots_NNS under_IN liquid_JJ N_NNP 
          2_CD ,_, thawed_JJ each_DT afternoon_NN before_IN
          administration_NN to_TO mice_NNS ,_, and_CC uneaten_NN food_NN was_VBD discarded_VBN
          daily_RB ._.
        
        
          Mice_NNS ,_, feeding_NN ,_, and_CC dissection_NN conditions_NNS
          Prior_RB to_TO actual_JJ experimentation_NN ,_, test_NN dissections_NNS were_VBD
          made_VBN on_IN identical_JJ mice_NNS to_TO perfect_JJ the_DT dissection_NN
          techniques_NNS at_IN Porsolt_NNP &_CC Partners_NNPS Pharmacology_NNP (_( Paris_NNP ,_,
          France_NNP )_) ._.
          Male_NNP Rj_NNP :_: NMRI_NNP mice_NNS from_IN Elevage_NNP Janvier_NNP ,_, Le_NNP
          Genest-_NNP Saint-_NNP Isle_NNP France_NNP ,_, weighing_VBG 10_CD -_: 11_CD g_SYM at_IN delivery_NN
          and_CC 33_CD -_: 51_CD grams_NNS on_IN experimental_JJ d_SYM 42_CD ,_, were_VBD housed_VBN 10_CD per_IN
          cage_NN in_IN wire_NN cages_NNS with_IN bedding_NN and_CC normal_JJ light_JJ cycle_NN ._.
          Mice_NNS received_VBD 
          ad_NN libitum_NN quantities_NNS of_IN distilled_VBN
          water_NN and_CC purified_JJ powdered_JJ diets_NNS (_( 7_CD ._. 5_LS g_SYM /_NN mouse_NN )_) in_IN
          ceramic_JJ cups_NNS (_( 10_CD /_NN group_NN )_) from_IN d_SYM 1_CD -_: 57_CD or_CC 58_CD ,_, and_CC were_VBD
          thereafter_RB sacrificed_JJ in_IN the_DT morning_NN by_IN cervical_JJ
          dislocation_NN over_IN these_DT last_JJ 2_CD experimental_JJ days_NNS ._. Food_NNP was_VBD
          not_RB removed_VBN the_DT night_NN before_RB ,_, and_CC since_IN nocturnal_NN mice_NNS
          are_VBP known_VBN to_TO eat_VB during_IN the_DT normal_JJ period_NN dark_JJ cycle_NN
          employed_VBN ,_, the_DT mice_NNS could_MD have_VB been_VBN fasted_JJ 0_CD -_: 6_CD h_NN at_IN
          sacrifice_NN ._. Mice_NNS were_VBD thus_RB not_RB completely_RB fasted_JJ at_IN
          sacrifice_NN ,_, a_DT complete_JJ fast_RB being_VBG 12_CD -_: 16_CD h_NN ._.
          After_IN feeding_NN diets_NNS to_TO 10_CD mice_NNS per_IN group_NN ,_, 5_CD mice_NNS were_VBD
          randomly_RB selected_VBN for_IN inclusion_NN in_IN hepatic_JJ and_CC
          hippocampal_NN gene_NN expression_NN analysis_NN ._. From_IN these_DT 5_CD mice_NNS ,_,
          livers_NNS were_VBD dissected_VBN according_VBG to_TO standard_JJ protocols_NNS
          (_( Porsolt_NNP &_CC Partners_NNPS Pharmacology_NNP ,_,
          Boulogne-_NNP Billancourt_NNP ,_, France_NNP )_) ,_, which_WDT consisted_VBD of_IN
          carefully_RB dissecting_VBG out_RP the_DT liver_NN ,_, rinsing_VBG with_IN 70_CD %_NN EtOH_NNP
          to_TO remove_VB adhering_VBG blood_NN ,_, trimming_NN of_IN adhering_VBG connective_JJ
          tissue_NN with_IN scissors_NNS ,_, cutting_VBG into_IN 100_CD -_: 150_CD mg_NN
          subsections_NNS ,_, freezing_NN in_IN liquid_JJ N_NNP 
          2_CD ,_, and_CC storing_VBG at_IN -_: 80_CD °_NN C_NNP until_IN gene_NN
          expression_NN and_CC lipid_NN analysis_NN ._. From_IN these_DT same_JJ 5_CD mice_NNS ,_,
          the_DT hippocampus_JJ was_VBD dissected_VBN from_IN the_DT mice_NNS according_VBG to_TO
          standard_JJ protocols_NNS (_( Porsolt_NNP &_CC Partners_NNPS Pharmacology_NNP ,_,
          Boulogne-_NNP Billancourt_NNP ,_, France_NNP )_) ,_, rinsed_JJ as_IN described_VBN for_IN
          livers_NNS ,_, cut_VB into_IN 17_CD -_: 50_CD mg_NN subsections_NNS ,_, and_CC frozen_VBN as_IN
          described_VBN for_IN livers_NNS ._. Hepatic_NNP and_CC hippocampal_NN lipid_NN
          analysis_NN was_VBD performed_VBN according_VBG to_TO standard_JJ methods_NNS at_IN
          Lipomics_NNP ,_, Inc_NNP ._. (_( U_NNP ._. S_NNP ._. A_DT )_) on_IN individual_JJ mice_NNS (_( 
          n_NN =_SYM 5_LS )_) ._.
        
        
          Nucleic_NNP acid_NN preparation_NN
          Liver_NNP tissue_NN was_VBD extracted_VBN from_IN 5_CD individual_JJ mice_NNS per_IN
          group_NN and_CC extracted_VBN separately_RB using_VBG Qiagen_NNP RNeasy_NNP
          mini-kits_JJ (_( Basel_NNP ,_, Switzerland_NNP )_) according_VBG to_TO manufacturer_NN
          instructions_NNS ,_, except_IN that_DT RNeasy_NNP columns_NNS were_VBD impregnated_JJ
          with_IN DNase_NNP I_PRP (_( Roche_NNP ,_, Basel_NNP ,_, Switzerland_NNP )_) to_TO remove_VB any_DT
          genomic_JJ DNA_NNP contamination_NN ._.
          For_IN the_DT group_NN fed_VBD a_DT control_NN diet_NN ,_, two_CD independent_JJ
          hepatic_JJ pools_NNS (_( 
          n_NN =_SYM 2_LS )_) of_IN 10_CD μg_NN each_DT were_VBD created_VBN ,_,
          consisting_VBG of_IN equal_JJ amounts_NNS (_( 2_CD μg_NN )_) of_IN total_JJ RNA_NNP from_IN each_DT
          of_IN the_DT 5_CD aforementioned_JJ mice_NNS ._. This_DT was_VBD done_VBN to_TO assess_VB
          measurement_NN variability_NN ._. Secondly_RB ,_, a_DT separate_JJ piece_NN of_IN
          liver_NN was_VBD excised_VBN from_IN three_CD of_IN the_DT individual_JJ control_NN
          mice_NNS (_( 
          n_NN =_SYM 3_LS )_) to_TO additionally_RB and_CC
          independently_RB extract_VB a_DT second_RB set_NN of_IN RNA_NNP ;_: these_DT three_CD
          mice_NNS were_VBD chosen_VBN at_IN random_JJ from_IN the_DT group_NN of_IN five_CD ._. This_DT
          second_JJ round_NN of_IN extraction_NN was_VBD used_VBN to_TO independently_RB
          assess_VB the_DT variability_NN of_IN normal_JJ control_NN mice_NNS housed_VBN
          under_IN the_DT prevailing_VBG conditions_NNS of_IN the_DT study_NN ._.
          For_IN each_DT of_IN the_DT other_JJ dietary_JJ groups_NNS ,_, a_DT single_JJ pool_NN (_( 
          n_NN =_SYM 1_LS )_) of_IN 10_CD μg_NN total_JJ hepatic_JJ RNA_NNP
          was_VBD created_VBN for_IN comparison_NN against_IN the_DT control_NN ._.
          Hippocampal_NNP RNA_NNP was_VBD prepared_VBN as_IN described_VBN above_IN for_IN
          hepatic_JJ RNA_NNP ,_, except_IN only_RB 1_CD pooled_VBN control_NN RNA_NNP sample_NN from_IN
          5_CD mice_NNS was_VBD prepared_VBN ;_: hence_RB there_EX was_VBD a_DT total_NN of_IN 4_CD pooled_VBN
          hippocampal_NN samples_NNS ,_, 
          i_NNP ._. e_SYM ._. one_CD from_IN each_DT of_IN the_DT 4_CD diets_NNS
          (_( Control_NNP ,_, FUNG_NNP ,_, FISH_NNP ,_, and_CC FUNG_NNP +_NN FISH_NNP )_) ._. In_IN sum_NN ,_, eight_CD liver_NN
          samples_NNS and_CC four_CD hippocampal_NN RNA_NNP samples_NNS were_VBD hybridized_JJ
          on_IN Affymetrix_NNP GeneChips_NNP ._.
          All_DT RNA_NNP samples_NNS were_VBD quantified_VBN with_IN the_DT RiboGreen_NNP RNA_NNP
          Quantification_NNP Kit_NNP (_( Molecular_NNP Probes_NNP ,_, Eugene_NNP Oregon_NNP )_) ,_,
          then_RB analyzed_VBD via_IN agarose_NN gel_NN electrophoresis_NNS for_IN intact_JJ
          18_CD S_NNP and_CC 28_CD S_NNP rRNA_NN ._. All_DT study_NN samples_NNS were_VBD judged_VBN to_TO
          contain_VB sufficient_JJ amounts_NNS of_IN high-quality_JJ RNA_NNP for_IN
          hybridization_NN to_TO GeneChips_NNP ._. As_IN another_DT quality_NN control_NN
          measure_NN ,_, prior_RB to_TO hybridization_NN with_IN Affymetrix_NNP GeneChips_NNP
          (_( Affymetrix_NNP ,_, Inc_NNP ._. ,_, Santa_NNP Clara_NNP ,_, CA_NNP )_) ,_, we_PRP confirmed_VBD that_WDT
          pooled_VBN samples_NNS gave_VBD strong_JJ signals_NNS using_VBG Affymetrix_NNP test_NN
          chips_NNS ._.
        
        
          Gene_NNP expression_NN analysis_NN using_VBG the_DT murine_NN 11_CD k_NN
          GeneChip_NNP
          
            cRNA_NN preparation_NN
            For_IN the_DT control_NN diet_NN group_NN ,_, each_DT of_IN three_CD individual_JJ
            mouse_NN liver_NN RNA_NNP samples_NNS (_( 
            n_NN =_SYM 3_LS )_) were_VBD hybridized_JJ to_TO
            Affymetrix_NNP GeneChips_NNP ._. For_IN both_DT the_DT control_NN and_CC LC-PUFA_NNP
            diets_NNS ,_, 15_CD μg_NN pooled_VBN total_JJ RNA_NNP was_VBD the_DT starting_VBG material_NN
            for_IN hybridization_NN to_TO the_DT Mu_NNP 11_CD kA_NN &_CC B_NNP GeneChips_NNP ._.
            Pooled_NNP liver_NN controls_NNS were_VBD evaluated_VBN in_IN duplicate_VB on_IN
            the_DT Affymetrix_NNP probe_NN array_NN cartridge_NN to_TO estimate_VB
            experimental_JJ variation_NN in_IN gene_NN chip_NN hybridization_NN ,_, as_RB
            previously_RB described_VBD in_IN detail_NN [_NN 27_CD ]_NN ._.
            In_IN all_DT cases_NNS ,_, total_JJ RNA_NNP was_VBD converted_VBN to_TO
            biotinylated_JJ cRNA_NN ,_, hybridized_JJ in_IN the_DT Affymetrix_NNP probe_NN
            array_NN cartridge_NN ,_, stained_JJ ,_, and_CC then_RB quantified_VBN ._. First_LS
            and_CC second_JJ strand_NN cDNA_NN synthesis_NN was_VBD performed_VBN using_VBG
            the_DT SuperScript_NNP Choice_NNP System_NNP (_( Invitrogen_NNP AG_NNP ,_, Basel_NNP ,_,
            Switzerland_NNP )_) ,_, according_VBG to_TO manufacturer_NN instructions_NNS ,_,
            but_CC using_VBG an_DT oligo-d_JJ T_NN primer_NN containing_VBG a_DT T_NN 7_CD RNA_NNP
            polymerase_NN binding_JJ site_NN ._. Labeled_NNP cRNA_NN was_VBD prepared_VBN with_IN
            the_DT MEGAscript_NNP 
            In_IN Vitro_NNP Transcription_NNP kit_NN
            (_( Ambion_NNP ,_, Inc_NNP ._. ,_, Austin_NNP ,_, TX_NNP )_) ._. Biotinylated_NNP CTP_NNP and_CC UTP_NNP
            (_( Enzo_NNP Biochem_NNP Inc_NNP ._. ,_, NY_NNP )_) were_VBD used_VBN together_RB with_IN
            unlabeled_JJ dNTPs_NNS in_IN the_DT reaction_NN ,_, and_CC unincorporated_JJ
            nucleotides_NNS were_VBD removed_VBN with_IN RNeasy_NNP columns_NNS ._.
          
          
            Array_NNP hybridization_NN and_CC scanning_VBG
            cRNA_NN (_( 10_CD μg_NN )_) was_VBD fragmented_JJ at_IN 94_CD °_NN C_NNP for_IN 35_CD min_NN in_IN
            buffer_NN containing_VBG 40_CD mM_NN Tris-acetate_NNP pH_NN 8_CD ._. 1_CD ,_, 100_CD mM_NN
            KOAc_NNP ,_, 30_CD mM_NN MgOAc_NNP ._. Prior_RB to_TO hybridization_NN ,_, fragmented_JJ
            cRNA_NN in_IN a_DT 6_CD X_NNP SSPE-T_NNP hybridization_NN buffer_NN (_( 6_CD X_NNP :_: 1_CD M_NNP NaCl_NNP ,_,
            10_CD mM_NN Tris_NNP pH_NN 7_CD ._. 6_CD ,_, 0_CD ._. 005_CD %_NN Triton_NNP )_) ,_, was_VBD heated_VBN to_TO 95_CD °_NN C_NNP
            for_IN 5_CD min_NN ,_, cooled_VBN to_TO 40_CD °_NN C_NNP and_CC loaded_VBN onto_IN an_DT Affymetrix_NNP
            probe_NN array_NN cartridge_NN ._. The_DT probe_NN array_NN was_VBD incubated_JJ
            for_IN 16_CD h_NN at_IN 40_CD °_NN C_NNP at_IN constant_JJ rotation_NN (_( 60_CD rpm_NN )_) ,_, then_RB
            exposed_VBN to_TO 10_CD washes_NNS in_IN 6_CD X_NNP SSPE-T_NNP at_IN 25_CD °_NN C_NNP followed_VBN by_IN 4_CD
            washes_NNS in_IN 0_CD ._. 5_CD X_NNP SSPE-T_NNP at_IN 50_CD °_NN C_NNP ._. Biotinylated_NNP cRNA_NN was_VBD
            stained_JJ with_IN 10_CD g_SYM /_NN mL_NN streptavidin-phycoerythrin_JJ
            conjugate_NN (_( Molecular_NNP Probes_NNP )_) in_IN 6_CD X_NNP SSPE-T_NNP for_IN 30_CD min_NN at_IN
            25_CD °_NN C_NNP followed_VBN by_IN 10_CD washes_NNS in_IN 6_CD xSSPE-T_JJ at_IN 25_CD °_NN C_NNP ._. Probe_NNP
            arrays_NNS were_VBD scanned_JJ at_IN 560_CD nm_NN using_VBG a_DT confocal_NN laser_NN
            scanning_VBG microscope_NN (_( made_VBN for_IN Affymetrix_NNP by_IN
            Hewlett-_NNP Packard_NNP )_) ._. Readings_NNP from_IN the_DT quantitative_JJ
            scanning_VBG were_VBD analyzed_VBN with_IN Affymetrix_NNP Gene_NNP Expression_NNP
            Analysis_NNP Software_NNP ._.
          
          
            Selection_NN of_IN differentially_RB regulated_VBN genes_NNS and_CC
            data_NNS analysis_NN
            A_DT mathematical_JJ method_NN was_VBD developed_VBN and_CC applied_VBN to_TO
            the_DT raw_JJ GeneChip_NNP data_NNS for_IN the_DT selection_NN of_IN
            differentially_RB regulated_VBN genes_NNS ._. This_DT method_NN moves_NNS
            beyond_IN setting_VBG a_DT single_JJ fold_VB change_NN cut-off_JJ by_IN
            considering_VBG fold_VB change_NN in_IN the_DT context_NN of_IN absolute_JJ
            expression_NN [_NN 27_CD ]_NN ._. In_IN brief_JJ ,_, this_DT method_NN includes_VBZ :_: (_( A_DT )_)
            the_DT determination_NN of_IN the_DT upper_JJ 5_CD %_NN of_IN fold_VB changes_NNS
            within_IN narrow_JJ bins_NNS of_IN absolute_JJ expression_NN levels_NNS to_TO
            determine_VB a_DT limit_NN fold_VB change_NN (_( LFC_NNP )_) function_NN ;_: and_CC (_( B_NNP )_)
            subsequent_JJ ranking_NN of_IN genes_NNS by_IN a_DT combined_VBN fold_VB
            change_NN /_NN absolute_JJ difference_NN calculation_NN ._. Herein_NNP ,_,
            absolute_JJ expression_NN is_VBZ referred_VBN to_TO as_IN average_JJ
            difference_NN intensity_NN (_( ADI_NNP )_) in_IN all_DT mathematical_JJ
            equations_NNS ._. The_DT function_NN describing_VBG the_DT upper_JJ 5_CD %_NN of_IN
            hippocampal_NN and_CC liver_NN data_NNS was_VBD described_VBN with_IN the_DT
            following_JJ equations_NNS :_: LFC_NNP 
            hippocampus_JJ =_SYM 1_CD ._. 36_CD +_NN (_( 90_CD /_NN min_NN ADI_NNP )_) ;_:
            and_CC LFC_NNP 
            liver_NN =_SYM 1_CD ._. 52_CD +_NN (_( 100_CD /_NN min_NN ADI_NNP )_) ,_,
            respectively_RB ._.
            The_DT selection_NN of_IN differentially_RB expressed_VBD genes_NNS was_VBD
            corroborated_JJ in_IN three_CD ways_NNS for_IN liver_NN samples_NNS :_: (_( 1_LS )_)
            assessing_VBG the_DT measurement_NN variability_NN and_CC (_( 2_LS )_) assessing_VBG
            individual_JJ mouse_NN variability_NN in_IN order_NN to_TO establish_VB
            confidence_NN intervals_NNS with_IN which_WDT to_TO calculate_VB the_DT
            significance_NN of_IN differences_NNS with_IN pooled_VBN diet_NN response_NN
            groups_NNS and_CC (_( 3_LS )_) confirmation_NN by_IN RT-PCR_NNP for_IN a_DT
            sub-selection_JJ of_IN genes_NNS ._. Replicate_NNP analysis_NN established_VBN
            that_IN all_DT genes_NNS selected_VBN by_IN this_DT method_NN also_RB laid_VBD above_IN
            a_DT more_RBR conventional_JJ 99_CD ._. 9_CD %_NN confidence_NN interval_NN ,_, when_WRB
            compared_VBN to_TO the_DT variation_NN of_IN pooled_VBN replicates_NNS (_( 
            n_NN =_SYM 2_LS )_) ._. Subsequent_JJ analysis_NN of_IN
            the_DT variation_NN between_IN individual_JJ mice_NNS (_( 
            n_NN =_SYM 3_LS )_) indicated_VBD that_IN this_DT
            variation_NN is_VBZ comparable_JJ to_TO the_DT pooled_VBN variation_NN and_CC
            that_IN all_DT genes_NNS selected_VBN as_RB differentially_RB expressed_VBD
            lied_VBD above_IN the_DT 99_CD ._. 0_CD %_NN confidence_NN interval_NN for_IN individual_JJ
            mouse_NN variability_NN ._. The_DT gene_NN expression_NN means_NNS of_IN the_DT
            three_CD individual_JJ mice_NNS were_VBD calculated_VBN and_CC compared_VBN to_TO
            pooled_VBN data_NNS in_IN a_DT scatter_NN plot_NN ._. A_DT correlation_NN
            co-efficient_JJ of_IN 0_CD ._. 93_CD was_VBD obtained_VBN indicating_VBG that_IN the_DT
            pools_NNS are_VBP accurate_JJ representations_NNS of_IN the_DT individual_JJ
            mice_NNS used_VBN to_TO create_VB them_PRP ._. Lastly_NNP ,_, validation_NN studies_NNS
            showed_VBD up_IN to_TO 85_CD ._. 7_CD %_NN concordance_NN of_IN microarray_NN data_NNS with_IN
            real_JJ time_NN polymerase_NN chain_NN reaction_NN (_( RT-PCR_NNP )_) across_IN the_DT
            range_NN of_IN absolute_JJ expression_NN for_IN specific_JJ genes_NNS
            selected_VBN as_RB differentially_RB regulated_VBN [_NN 27_CD ]_NN ._. All_DT
            RT-PCR_NNP data_NN ,_, including_VBG information_NN about_IN the_DT low_JJ false_JJ
            positive_JJ rate_NN ,_, for_IN all_DT of_IN the_DT liver_NN samples_NNS mentioned_VBN
            in_IN the_DT present_JJ work_NN ,_, can_MD be_VB found_VBN in_IN the_DT aforementioned_JJ
            reference_NN ._.
            The_DT 5_CD %_NN LFC_NNP method_NN indicated_VBD that_IN 513_CD genes_NNS in_IN the_DT
            hippocampus_JJ and_CC 489_CD genes_NNS in_IN the_DT liver_NN were_VBD
            differentially_RB regulated_VBN by_IN LC-PUFA_NNP from_IN the_DT original_JJ
            13_CD ,_, 179_CD genes_NNS represented_VBD on_IN the_DT Mu_NNP 11_CD K_NNP Affymetrix_NNP
            GeneChip_NNP ._. Absence_NNP /_NN presence_NN calls_NNS were_VBD not_RB considered_VBN 
            a_DT priori_FW in_IN selecting_VBG
            significantly_RB regulated_VBN genes_NNS ,_, but_CC were_VBD a_DT
            post-selection_JJ criterion_NN ._. After_IN removing_VBG those_DT genes_NNS
            that_WDT were_VBD identified_VBN as_IN 
            absent_JJ across_IN all_DT dietary_JJ
            conditions_NNS ,_, 356_CD hippocampal_NN and_CC 329_CD hepatic_JJ
            differentially_RB expressed_VBD probe_NN sets_NNS remained_VBD in_IN the_DT
            list_NN for_IN further_JJ analysis_NN and_CC interpretation_NN ._. Of_IN these_DT ,_,
            221_CD and_CC 214_CD genes_NNS represented_VBD annotated_JJ sequences_NNS in_IN
            the_DT hippocampus_JJ and_CC liver_NN ,_, respectively_RB ._.
            Fold_NNP changes_NNS are_VBP always_RB listed_VBN in_IN the_DT respective_JJ
            order_NN :_: FUNG_NNP ,_, FISH_NNP ,_, and_CC FUNG_NNP +_NN FISH_NNP without_IN repeating_VBG
            these_DT labels_NNS ;_: and_CC negative_JJ signs_NNS indicate_VBP down_RB
            regulation_NN ._. To_TO determine_VB if_IN the_DT ADI_NNP for_IN a_DT treatment_NN
            group_NN was_VBD significantly_RB different_JJ from_IN the_DT control_NN
            diet_NN ,_, the_DT 5_CD %_NN LFC_NNP best-fit_JJ equations_NNS were_VBD utilized_JJ :_: LFC_NNP 
            hippocampus_JJ =_SYM 1_CD ._. 36_CD +_NN (_( 90_CD /_NN min_NN ADI_NNP )_) ;_:
            LFC_NNP 
            liver_NN =_SYM 1_CD ._. 52_CD +_NN (_( 100_CD /_NN min_NN ADI_NNP )_) ._. Groups_NNS
            significantly_RB different_JJ from_IN the_DT control_NN ,_, as_IN determined_VBN
            by_IN a_DT pair-wise_JJ comparison_NN ,_, are_VBP labeled_VBN with_IN an_DT asterisk_NN
            in_IN the_DT text_NN and_CC Table_NNP 2_CD ._. The_DT mathematical_JJ model_NN
            utilized_JJ also_RB selected_VBD some_DT genes_NNS due_JJ to_TO significant_JJ
            differences_NNS between_IN experimental_JJ treatments_NNS ,_, even_RB when_WRB
            no_DT significant_JJ differences_NNS versus_CC the_DT control_NN were_VBD
            observed_VBN ._. For_IN reasons_NNS of_IN simplicity_NN ,_, significant_JJ
            differences_NNS between_IN experimental_JJ treatments_NNS are_VBP not_RB
            indicated_VBN in_IN Table_NNP 2_CD ,_, but_CC are_VBP discussed_VBN in_IN the_DT
            text_NN ._.
          
          
            Data_NNP analysis_NN
            Selected_JJ genes_NNS were_VBD grouped_VBN by_IN expression_NN patterns_NNS
            through_IN a_DT combined_VBN 
            k_NN -_: means_VBZ and_CC hierarchical_JJ
            clustering_VBG approach_NN (_( Spotfire_NNP ,_, Inc_NNP ._. ,_, Sommerville_NNP ,_, MA_NNP )_)
            by_IN setting_VBG the_DT maximum_NN number_NN of_IN clusters_NNS in_IN either_DT
            method_NN to_TO 5_CD (_( a_DT compromise_NN between_IN not_RB having_VBG too_RB many_JJ
            or_CC too_RB few_JJ clusters_NNS )_) and_CC then_RB graphing_VBG on_IN a_DT 2_CD -_: D_NNP gene_NN
            plot_NN (_( Figures_NNS not_RB shown_VBN ;_: hierarchical_JJ cluster_NN numbers_NNS
            (_( h_NN 1_CD -_: h_NN 5_LS )_) ,_, and_CC 
            k_NN -_: means_VBZ cluster_NN number_NN (_( k_NN 1_CD -_: 5_LS )_)
            included_VBN in_IN Table_NNP 2_LS )_) ._. Genes_NNP were_VBD then_RB annotated_JJ using_VBG
            gene_NN ontology_NN (_( GO_NNP )_) classifications_NNS ;_: a_DT dynamic_NN ,_,
            structured_VBN ,_, yet_RB precisely_RB defined_VBN system_NN which_WDT
            characterizes_VBZ genes_NNS based_VBN on_IN defined_VBN categories_NNS of_IN
            molecular_JJ function_NN ,_, biological_JJ process_NN ,_, and_CC cellular_JJ
            component_NN [_NN 28_CD ]_NN ._. Finally_RB ,_, genes_NNS were_VBD assigned_VBN names_NNS
            through_IN NCBI_NNP Locuslink_NNP (_( Table_NNP 2_LS )_) ._.
          
          
            Gene_NNP Confirmation_NNP
            A_DT subset_NN of_IN the_DT genes_NNS selected_VBN by_IN the_DT 5_CD %_NN LFC_NNP model_NN
            were_VBD examined_VBN by_IN RT-PCR_NNP using_VBG SYBR_NNP ®_NN green_JJ dye_NN
            (_( Molecular_NNP Probes_NNP )_) which_WDT interacts_NNS with_IN double-stranded_JJ
            nucleotide_NN sequences_NNS ._. Data_NNP represented_VBD means_NNS of_IN
            triplicates_NNS for_IN each_DT experimental_JJ treatment_NN using_VBG
            pooled_VBN RNA_NNP samples_NNS (_( 
            n_NN =_SYM 5_LS )_) ._. Amplification_NNP was_VBD
            performed_VBN using_VBG an_DT ABI_NNP 5700_CD machine_NN (_( Applied_NNP
            Biosystems_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP ,_, USA_NNP )_) with_IN a_DT hot_JJ start_NN at_IN
            95_CD °_NN C_NNP for_IN 10_CD minutes_NNS ,_, followed_VBN by_IN 40_CD cycles_NNS of_IN 95_CD °_NN C_NNP for_IN
            15_CD s_VBZ and_CC 60_CD °_NN C_NNP for_IN 1_CD min_NN for_IN denaturation_NN ,_, annealing_VBG and_CC
            elongation_NN ._. Data_NNP was_VBD normalized_JJ to_TO β-actin_JJ and_CC GAPDH_NNP ,_,
            which_WDT were_VBD not_RB statistically_RB ,_, differentially_RB expressed_VBD ._.
            A_DT students_NNS 
            t_NN -_: test_NN (_( α_NN =_SYM 0_CD ._. 05_CD )_) was_VBD used_VBN to_TO
            confirm_VB significantly_RB differentially_RB expressed_VBD genes_NNS
            following_VBG RT-PCR_NNP ._.
          
          
            Lipid_NNP analysis_NN
            Following_VBG sacrifice_NN of_IN the_DT animals_NNS ,_, the_DT livers_NNS (_( 250_CD
            mg_NN piece_NN )_) ,_, hippocampus_JJ (_( from_IN half_NN of_IN the_DT mice_NNS )_) ,_, and_CC
            whole_JJ brains_NNS (_( from_IN the_DT other_JJ half_NN of_IN mice_NNS )_) from_IN each_DT
            animal_NN were_VBD rapidly_RB frozen_VBN in_IN liquid_JJ N_NNP 
            2_CD and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ._. Each_DT whole_JJ
            brain_NN weighed_VBD between_IN 395_CD -_: 454_CD mg_NN ._. A_DT slurry_NN of_IN each_DT
            whole_JJ brain_NN was_VBD made_VBN by_IN thawing_VBG the_DT tissue_NN samples_NNS at_IN
            room_NN temperature_NN for_IN the_DT minimum_JJ time_NN necessary_JJ ,_, adding_VBG
            12_CD ._. 6_CD mL_NN of_IN CHCL_NNP 3_CD :_: MeOH_NNP (_( 2_CD :_: 1_CD ,_, v_NN /_NN v_NN )_) ,_, briefly_NN homogenizing_VBG
            on_IN ice_NN ,_, and_CC re-freezing_JJ the_DT samples_NNS under_IN N_NNP 
            2_CD at_IN -_: 80_CD °_NN C_NNP (_( concentration_NN was_VBD ca_MD ._. 30_CD
            mg_NN brain_NN /_NN mL_NN solvent_JJ )_) ._. Livers_NNP ,_, hippocampus_JJ ,_, and_CC whole_JJ
            brain_NN (_( 4_CD individual_JJ samples_NNS /_NN tissue_NN )_) were_VBD quantitatively_RB
            analyzed_VBN for_IN FA_NNP distribution_NN (_( μg_NN FA_NNP /_NN g_SYM tissue_NN )_) in_IN each_DT
            PL_NNP class_NN ,_, by_IN Lipomics_NNP Technologies_NNPS ,_, Inc_NNP ._. (_( West_NNP
            Sacramento_NNP ,_, CA_NNP )_) ._. Brain_NNP samples_NNS were_VBD also_RB separately_RB
            extracted_VBN ,_, and_CC 
            N_NNP -_: acylethanolamines_NNS (_( NAEs_NNP )_) and_CC
            monoacylglycerols_NNS (_( MAGs_NNP )_) purified_JJ and_CC characterized_VBN as_RB
            previously_RB described_VBD in_IN detail_NN [_NN 84_CD ]_NN ._.
          
        
      
      
        Abbreviations_NNP
        AA_NN arachidonic_JJ acid_NN
        ACC_NNP acetyl_NN CoA_NNP carboxylase_NN
        ADI_NNP average_JJ difference_NN intensity_NN
        DHA_NNP docosahexaenoic_JJ acid_NN
        EPA_NNP eicosapentaenoic_JJ acid_NN
        FA_NNP (_( s_VBZ )_) fatty_NN acid_NN (_( s_VBZ )_)
        FISH_NNP fish_NN oil_NN
        FUNG_NNP fungal_NN oil_NN
        FUNG_NNP +_NN FISH_NNP refers_VBZ to_TO the_DT combination_NN of_IN fungal_NN and_CC fish_NN
        oils_NNS fed_VBN together_RB
        GO_NNP gene_NN ontology_NN
        HNF_NNP hepatic_JJ nuclear_JJ factor_NN
        LC-PUFA_NNP long_JJ chain_NN polyunsaturated_JJ fatty_NN acid_NN
        LFC_NNP limit_NN fold_VB change_NN
        LXR_NNP liver_NN X_NNP receptor_NN
        LXRE_NNP LXR_NNP responsive_JJ elements_NNS
        PL_NNP phospholipid_NN
        PPAR_NNP peroxisome_NN proliferator_NN activated_VBN receptor_NN
        RT-PCR_NNP real_JJ time-polymerase_JJ chain_NN reaction_NN
        SRE_NNP (_( BP_NNP )_) sterol_NN regulatory_JJ element_NN (_( binding_JJ protein_NN )_)
      
      
        Authors_NNP '_'' contributions_NNS
        AB_NNP designed_VBD and_CC processed_VBD the_DT 
        in_IN vivo_NN mice_NNS experiments_NNS that_WDT led_VBD to_TO
        the_DT basic_JJ structure_NN of_IN this_DT work_NN ._. AB_NNP also_RB was_VBD responsible_JJ
        for_IN identifying_VBG many_JJ of_IN the_DT specific_JJ lipid-gene_JJ
        correlations_NNS in_IN the_DT two_CD datasets_NNS and_CC putting_VBG them_PRP in_IN the_DT
        context_NN of_IN nutritional_JJ biochemistry_NN ._. DMM_NNP analyzed_VBD ,_,
        integrated_VBN and_CC organized_VBD all_DT of_IN the_DT microarray_NN data_NN ._. DMM_NNP
        performed_VBD and_CC analyzed_VBN all_DT of_IN the_DT RT-PCR_NNP confirmation_NN
        studies_NNS ._. Both_DT DMM_NNP and_CC MR_NNP were_VBD responsible_JJ for_IN developing_VBG
        the_DT mathematical_JJ algorithms_NNS used_VBN for_IN the_DT identification_NN of_IN
        differential_NN gene_NN expression_NN ._. MR_NNP led_VBD the_DT overall_JJ
        integration_NN of_IN the_DT lipid-gene_JJ datasets_NNS and_CC organized_VBD the_DT
        writing_NN of_IN this_DT manuscript_NN ._. JBG_NNP put_VBD the_DT data_NNS and_CC
        conclusions_NNS into_IN context_NN with_IN previous_JJ literature_NN and_CC
        emerging_VBG trends_NNS in_IN the_DT field_NN of_IN nutrition_NN ._.
        All_DT authors_NNS have_VBP read_VBN and_CC approved_VBD the_DT final_JJ
        manuscript_NN ._.
      
    
  
